Environmental and Health Assesment of Alternatives to Phthalates and to
flexible PVC
5.1 Di(ethylhexyl) adipate; 103-23-1
5.1.1 Use, emission and exposure
5.1.2 Health assessment
5.1.3 Environmental assessment
5.2 O-acetyl tributyl citrate; 77-90-7
5.2.1 Use, emission and exposure
5.2.2 Health assessment
5.2.3 Environmental assessment
5.3 Di(2-ethylhexyl) phosphate; 298-07-7
5.3.1 Use, emission and exposure
5.3.2 Health assessment
5.3.3 Environmental assessment
5.4 Tri(2-ethylhexyl) phosphate; 78-42-2
5.4.1 Use, emission and exposure
5.4.2 Health assessment
5.4.3 Environmental assessment
5.5 Tri-2-ethylhexyl trimellitate; 3319-31-1
5.5.1 Use, emission and exposure
5.5.2 Health assessment
5.5.3 Environmental assessment
5.6 O-toluene sulfonamide; 88-19-7
5.6.1 Use, emission and exposure
5.6.2 Health assessment
5.6.3 Environmental assessment
5.7 2,2,4-trimethyl 1,3-pentandiol diisobutyrate;
6846-50-0
5.7.1 Use, emission and exposure
5.7.2 Health assessment
5.7.3 Environmental assessment
5.8 Epoxidised soybean oil; 8013-07-8
5.8.1 Use, emission and exposure
5.8.2 Health assessment
5.8.3 Environmental assessment
5.9 Dipropylene glycol dibenzoate; 27138-31-4
5.9.1 Use, emission and exposure
5.9.2 Health assessment
5.9.3 Environmental assessment
5.10 Dioctyl sebacate; 122-62-3
5.10.1 Use, emission and exposure
5.10.2 Health assessment
5.10.3 Environmental assessment
5.11 Polyester (polyadipates)
Datasheets for the assessed substances appear in appendix and provide
detailed information. Here, the key data are presented and used for the
assess-ment. The results of the exposure and dose calculations performed
with EUSES are presented in tables. The selected scenarios cover consumer
exposure, exposure in the workplace and exposure from the environment. In
the tables presenting regional concentrations Surfacet and
Surfaced
denotes concentration of the substance in the total water and in the
dissolved phase, respectively. The toxicity data selected for the
assessment of human toxicity are primarily observations in humans (where
available) and test results from standard animal tests used in
classification of chemical substances in accordance with the EU Substance
Directive (EEC 1967). In presenting human toxicity data the tables contain
what is considered the core data regarding the effects. These and
additional data can be found in the appendix. The information used for the
evaluation is discussed in the text. Acute toxicity, irritation,
sensitivity, subchronic toxicity and long-term ef-fects are discussed
where possible. If a NOAEL or a LOAEL is established, this estimate is
included in the assessment and also discussed in relation to the selected
exposure scenarios. If an ADI-value is established for the substances,
the calculated exposure scenarios are discussed in the light of this value
taking all possible exposure routes and situations into consideration. The
ecotoxicity data have been selected with preference to results based on
the standard ecotoxicity test methods for algae, crustaceans and fish, as
recommended in Pedersen et al. (1995) and used in the environmental
hazard classification process. Thus, in the case where the acute test is
the 72 hours algae test (IC50), 48 hours crustacean test (EC50), and 96
hours fish test (LC50), the result in mg/l is presented without further
explanation. If the result comes from a test of other duration or
endpoint etc, the deviation will be stated. For biodegradation the
standard test is the 28 days of readily or in-herent degradability. Unless
it is stated otherwise, all BCF data are measured, and values above 100
are considered indicative of bioaccumulative properties.
Adipates are (as sebacates and azalates) diesters of aliphatic
dicarboxylic acids and are produced with varying alcohol groups.
The adipates are classified as low temperature plasticisers. The
compounds of this group are all relatively sensitive to water.
Physical-chemical properties
The measured solubility of di(ethylhexyl) adipate (DEHA) in water at
20-22 ºC ranges from 0.8 mg/l to <100 mg/l,
which places this substance in the group of the moderately soluble
substances investigated in this assessment.
DEHA has a measured vapour pressure at 20-25 ºC ranging from 8.5 10-7 to 2.6 mm
Hg. A value of 8.5 1 10-5 is used
for the assessment. The magnitude of this parameter places DEHA in the
group of investigated substances that possesses a moderate to low vapour
pressure.
The estimated LogPow values of 4.2 to 8.1 (BUA 1996a) and
one measured value of > 6.1 (HSDB 2000) indicates that this substance
is lipophilic. The default maximum value of 6 was used for the EUSES
estimation.
Migration
The measured reduced migration potential (household cling to olive oil) of
2.6-41.3 mg/dm2 indicates that DEHA have the potential of
migrating from the PVC phase to a fatty phase in contact with the PVC
(Petersen, Breindahl, 1998). In the same study other plasticisers such as
dibutyl phthalate (DBP) were shown to possess lower migration potentials
(0.2-1.1 mg/dm2) relative to DEHP.
Use pattern for compound
DEHA is the dominant compound in the group of adipates, and is mostly used
in thin clear household cling intended for food wrapping.
As seen in Table 4.6 DEHA is expected to be widely used in the near
future to in various areas such as in products for the hospital sector and
in packaging. DEHA is also expected to be used in products such as
printing inks, adhesives, fillers and products now containing various
amounts of PVC-plastic.
Exposure in work place
The EASE calculation focuses on the production of floor and wall
coverings.
The following assumptions are made with regard to the process:
- a press is used for production
- the temperature is 200 ºC
- a required legal exhaust ventilation is in place.
Possible main exposure routes in the workplace:
- inhalation of vapours and aerosols
- skin contact from contact with aerosols is considered to be
insignificant.
Based on this scenario, the EASE calculation gives the following
estimates of exposures shown in Table 5.1.
Table 5.1 Estimated values of DEHA in the working environment according
to the EASE calculation.
Route of exposure |
EASE value |
Unit |
Vapour concentration in air for workers |
10-50 |
ppm |
Vapour concentration in air for workers |
154-771 |
mg/m3 |
Potential dermal uptake for workers |
0 |
mg/kg/day |
Consumer exposure
The direct exposure from floor and wall coverings is estimated by an EASE
calculation and the results are shown in Table 5.2.
Table 5.2 The estimated potential daily intake of DEHA by consumers
according to the EASE calculation
Route of exposure |
Daily intake in mg/kg bw/day |
Ratio to the ADI
(0.3 mg/kg bw/d) |
Inhalatory intake |
4.34 x 10-10 |
1.45 x 10-7 |
Dermal uptake |
4.56 x 10-4 |
1.52 x 10-3 |
Oral intake |
0 |
0 |
Total chronic uptake via different routes |
4.56 x 10-4 |
0.0015 |
Total acute uptake via different routes |
0 |
0 |
The broad application of DEHA means that the total exposure of
consumers from all possible sources will be higher than the values
indicated in Table 5.2.
The ability of DEHA to migrate from plasticised products e.g. packing
materials to more lipophilic environments leads to the conclusion that the
potential exposure of consumers may be even larger, if DEHA is going to
substitute phthalates as described in the substitution matrixes.
Haemodialysis
Haemodialysis is selected as a second scenario for consumer exposure to
DEHA. This is the application where high exposure is identified for
bis(2-ethyl-hexyl)phthalate (DEHP) in KemI (2000).
In this scenario focussing on the use of DEHA in plasticised tubing for
haemodialysis, the concentration of DEHA in blood is estimated at 6.0 -
8.4 mg/l. This figure is reached using the following data and assumptions:
Re-circulation of PVC-tubing with humane plasma for five hours resulted
in extraction of 4.2 mg DEHA into a volume of 500-700 ml and thereby a
concentration of 6.0 - 8.4 mg/l in blood. If this amount of DEHA is
distributed to the full blood volume (5 l), the resulting concentration
would be 0.84 mg/l. This figure is probably lower than what would be
expected from a real dialysis situation, where the full blood volume is
re-circulated. A more realistic value is expected to be in the range of
0.84 - 8.4 mg/l blood after a single treatment. This corresponds to 16.8 -
168m g/kg bw for a 50 kg person per treatment
session. Assuming three treatments per week this will correspond to an
average daily exposure of 2.9 - 72m g/kg
bw/day.
Milk tubes
A special scenario has been set up for the use of DEHA in tubes used
when stripping cows.
According to (Jensen, 2000) plasticised tubes are only used for
transporting the milk 1 meter from the cow to the milk carrier system in
the stable. This tube is estimated to have a internal diameter on 1.6 cm
and an external on 1.8 cm and a length equal to 1 meter (Jepsen, 2000).
This leads to a volume of the tube equal to = 0.214 dm3 = 0.214
l. The density of the tube is estimated to 1 kg/l leading to a weight
equal to 0.214 kg. The lifetime is assumed to be one year.
The content of DEHA is 7-40% and this is estimated to migrate from the
tube 100% within the lifetime. The amount of DEHPA migrating from 1 metre
of tubing is 85,000 mg pr year.
It is assumed that the tube is used to strip 25 cows pr. year. One cow
produces 6,836 kg milk pr. year with a density of 1 kg/l.
In this scenario the minimum concentration of DEHA in the milk will be
0.088 mg/l and the maximum will be 0.50 mg/l. If a child weighing 10 kg
drinks 1 litre of milk per day, the average daily intake from this source
would be a maximum of 0.05 mg/kg bw/day.
Environmental exposure of human
The amount established in the ’Usage’ section is used to calculate
exposure for a number of environmental compartments by EU TGD/EUSES. The
dose is almost completely derived from consumption of root crops. This is
due to the extraordinary high LogPow of DEHA leading to
accumulation in agricultural soil when sludge is used for soil amendment.
No measured data are available for accumulation in plants.
Table 5.3 The estimated human doses of DEHA through intake of water,
fish, leaf of crops, roots of crops, meat, milk and air.
DEHA |
|
Estimation (~1,700t) |
Worst case (10,700t) |
|
|
mg/kg/d |
mg/kg/d |
Drinking water |
|
6 10-7 |
4 10-6 |
Fish |
BCF measured |
5 10-7 |
3 10-6 |
Plants |
Leaf crops |
0.00005 |
0.00033 |
|
Root crops |
0.007 |
0.047 |
Meat |
|
0.00011 |
0.00072 |
Milk |
|
0.00007 |
0.00042 |
Air |
|
1 10-7 |
6 10-7 |
Total regional |
|
0.0076 |
0.0481 |
Exposure in the environment
The estimated concentration levels of DEHA reflect the low solubility
in aqueous solutions combined with a high LogPow and a
resulting association with particles (sediment and soils).
Table 5.4 The estimated regional concentrations of DEHA in water, soil
and air.
Compartment |
Aquatic |
Terrestrial |
Air |
DEHA |
Surfacet |
Surfaced |
Sediment |
Natural |
Agricultural |
Porewater of agri. soil. |
Industrial |
|
|
mg/l |
mg/l |
mg/kg |
mg/kg |
mg/kg |
mg/l |
mg/kg |
mg/m3 |
Estimation (~1,700 t) |
0.000022 |
0.00001 |
0.24 |
0.0023 |
0.24 |
0.00002 |
1.9 |
4.5 x 10-5 |
Worst case |
0.00014 |
0.00007 |
1.5 |
0.015 |
1.6 |
0.00013 |
12 |
2.9 x 10-6 |
Secondary poisoning
The accumulated concentration in fish, roots of plants, meat and milk
reflects the estimated high lipophilicity of DEHA.
Table 5.5 The estimated regional concentrations of DEHA in fish,
plants, meat and milk.
Articles of food |
Wet fish |
Plants |
Meat |
Milk |
DEHA |
Estimate |
Measured |
Roots |
Leaves |
Grass |
|
|
|
mg/kg |
mg/kg |
mg/kg |
mg/kg |
mg/kgww |
mg/kgww |
mg/kgww |
Estimation (~1,700 t) |
0.48 |
2.8 x 10-4 |
1.3 |
0.003 |
0.003 |
0.03 |
0.008 |
Worst case (10,700 t) |
3.02 |
1.8 x 10-3 |
8.5 |
0.019 |
0.019 |
0.17 |
0.053 |
The key toxicity data for the assessment of DEHA are presented in Table
5.6.
Table 5.6 Selected toxicity data on DEHA.
Toxicology |
Species |
Protocol |
Dose levels / duration |
Results |
Ref. |
Acute oral toxicity |
Rat |
N.D. |
|
LD50=7,392 mg/kg bw |
1a, 5, 9 |
Acute inhalation toxicity |
Rat |
N.D. |
900 mg/m3 / 4h |
No effects |
11 |
Acute dermal toxicity |
Rabbit |
N.D. |
|
LD50=8,410 mg/kg bw |
1a, 4, 5, 10 |
Acute toxicity, other routes |
Rabbit |
N.D. |
|
LD50, i.v.=540 mg/kg bw |
1a, 4, 5, 12 |
|
Rat |
N.D. |
|
LD50, i.v.=900 mg/kg bw |
1a, 4, 5 |
|
Mouse |
N.D. |
|
LD50, i.p.=150 mg/kg bw |
1a |
Irritation
- skin |
Rabbit
(albino) |
Draize test |
462 mg/6.5 cm2
24 hour |
Slightly irritating (average of 0.83 points out of 8) |
5 |
- eye |
Rabbit |
N.D. |
462 mg (0.5 ml)
24 hours |
Small foci with necrotic tissue |
5 |
|
Rabbit |
N.D. |
0.1 ml (92.4 mg) |
Not irritating |
5 |
Sensitisation |
Guinea pig (♂) |
Draize |
i.c.:1. day: 0.1% (0.5 ml) + 3 0.1%
(0.1ml) for 3 weeks, Challenge: 0.1% (0.5ml) |
No effect |
5, 16 |
Repeated dose toxicity |
Mouse (B6C3F1) |
N.D |
240-3750 mg/kg/day; 13 weeks |
Reduced bodyweight gain at 465 mg/kg bw |
1a, 5, 7 |
|
Mouse (B6C3F1) |
Investigation of liver peroxisome proliferation (oral) |
0, 32, 325, 3322, 6370 mg/kg/day;
21 days |
Reduced bodyweight gain, increased liver weight and peroxisome
numbers in liver cells. NOAEL=325 mg/kg bw |
1b |
|
Rat (strain unknown) |
N.D. (oral) |
610-4760 mg/kg/day, 90 days |
Reduced bodyweight gain, changes in liver and kidney weight.
Adverse effects on liver, kidney, spleen and testes. NOAEL=610 mg/kg
bw |
1a, 5, 6 |
|
Rat (strain unknown) |
N.D. (oral) |
700 and 1,500 mg/kg/day;
2 years |
Reduced bodyweight gain, NOAEL=700 mg/kg/day, LOAEL= 1,500
mg/kg/day |
3 |
|
Rat (Fisher 344) |
Investigation of liver peroxisome proliferation (oral) |
11, 122, 1177, 2275 mg/kg/day;
up to 21 days |
Reduced bodyweight gain, increased liver weight and peroxisome
numbers in liver cells.
NOAEL=122 mg/kgbw |
1b |
Genetic toxicity |
Salmonella typhimurium |
Ames test, +/-
|
0.025-10 mg/plate |
Not mutagenic |
2, 3, 5, 13 |
|
Mouse |
Dominant lethal mutation study |
0, 0.45, 0.9, 4.6, 9.2 g/kg bw i.p. |
LOAEL=450 mg/kg bw
|
3, 5, 8 |
|
Human lymphocytes |
OECD 473
|
10, 50, 100m g/ml |
Negative
|
1a, 5, 14 |
|
CHO cells |
In vitro mammalian cell gene mutation test, +/- |
<400m g/ml |
Weak positive without S9 |
1a, 5, 15 |
Reproductive / developmental toxicity |
Rat, Alpk:APfSD |
Fertility study, OECD 415 |
28, 170 1,080 mg/kg/day; 10 weeks |
NOAEL, parental = 170 mg/kg bw/day
NOAEL, F0 = 170 mg/kg bw/day |
16
|
|
Rat, Alpk:APfSD |
Developmental, OECD 414 |
28, 170 1,080 mg/kg/day; 22 days |
NOAEL, foetotoxicity = 28 mg/kg bw/day
NOAEL, parental = 170 mg/kg bw/day, LOAEL = 1080 mg/kg bw/day. |
3, 5 |
Carcinogencity |
Mouse (B6C3F1)
|
N.D.
|
1,800 and 3,750 mg/kg bw/day, 103 weeks
|
Dose-dependent incidence of liver tumours (adenomas and
carcinomas). Significantly higher no. of ♀ with carcinomas. |
1a, 2, 5, 7
|
|
Rat
(Fisher 344) |
N.D. |
600 and 1,250 mg/kg bw/day, 103 weeks |
No substance related effect. |
1a, 5, 7 |
|
Rat (F-344) and mouse (B6C3F1) |
N.D. |
2.5 g/kg bw/day
Duration unknown |
Higher sensitivity for F-344 rats than B6C3F1 mice to peroxisome
proliferation. |
2 |
Experience with human exposure |
Human |
Inhalation |
11.7 - 14.6m g/m3 |
More pronounced reactions in humans with allergy case history |
1a, 5 |
|
Human |
Patch-test |
Neat DEHA, booster after 14 days |
No irritation or sensitisation |
5 |
References: 1a) European Commission Joint Research Centre (1996), 1b)
European Commission Joint Research Centre (2000), 2) HSDB (2000), 3) IRIS
(2000) 4) NTP (2000), 5) BUA (1996a), 6) Smyth et al. (1951), 7) DHHS/NTP
(1981), 8) Singh et al. (1975), 9) Kolmar Res. Ctr. (1967), 10) Union
Carbide quoted in Sax, N.J. and Lewis, R.J. Jr. (eds); (1989), 11)
Vandervort and Brooks (1977), 12) Edgewood Arsenal (1954), 13) Zeiger et
al. (1982), 14) ICI PLC (1989b), 15) Galloway et al (1987), 16) SIDS
dossier (1998).
Observations in humans
Most of the identified observations in humans are related to cosmetic
products with a certain content of DEHA, but without available information
regarding the other constituents. These observations are therefore not
used in the evaluation. Exposure to neat DEHA did not cause significant
irritation or sensitisation reactions (BUA, 1996a).
In the meatpacking industry, 685 workers were investigated. The average
DEHA concentration in the rooms was 11.7m g/m3
to 14.6m g/m3. Workers with
asthma or allergy seemed to get more pronounced reactions. No further
details are available (BUA, 1996a).
Acute toxicity
DEHA shows very little acute toxicity in animal studies. Administered
orally, the lowest observed LD50 in rat was 7,392 mg/kg bw. LD50
values (oral) in rat have been reported up to 45,000 mg/kg. Dermal LD50's
have been found in the range of 8,410 to 15,100 mg/kg in the rabbit
(European Commission Joint Research Centre, 1996).
When administered intravenously, DEHA is slightly more toxic, with a LD50
to rat of 900 mg/kg bw and a LD50 to rabbit of 540 mg/kg
bw (BUA, 1996a).
Based on the available limited data, DEHA does not show effects when
inhaled for a short period of time.
Irritation
DEHA has been reported to be non-irritating or slightly irritating to
the skin and eyes of rabbits in a number of different studies. Slight
irritation was observed in a study where 0.5 ml / 462 mg DEHA was applied
to rabbit skin for 24 hours. 462 mg of test substance instilled in the in
rabbit eye produced small foci with necrotism. Detailed information about
the test conditions and results are not available (BUA, 1996a).
Sensitisation
DEHA did not produce signs of a sensitising potential in a Draize test
in guinea pigs (BUA, 1996a).
Repeated dose toxicity
A number of different repeated dose toxicity studies have shown that DEHA
can produce dose dependent changes in body and organ weights and in
bio-chemical parameters as well as changes indicative of peroxisome
prolifera-tion. A precise determination of a NOAEL for DEHA for repeated
dose toxicity is not available. A NOAEL in rats of 610 mg/kg bw/day was
ob-served in a 13 week feeding study (Smyth et al., 1951). In rats a NOAEL
of 122 mg/kg bw/day for peroxisomal proliferation was identified in 21 day
feeding study, and in a similar study in mice the NOAEL was identified at
325 mg/kg bw/day (European Commission Joint Research centre, 2000). No
details are available in the reviewed literature. The Scientific Committee
for Food has assigned a NOAEL for DEHA in the rat, as measured by bio-chemical
parameters and electronmicroscopic analysis of peroxisome proliferation,
at approximately 100 mg/kg bw/day (CSTEE, 1999).
Genetic toxicity
The mutagenicity of DEHA is weak in the available studies and only
ob-served in mice. Most significant was an observed dominant lethal effect
in male mice, here the LOAEL was 450 mg/kg bw (Singh et al., 1975).
Long term toxicity
According to IARC, DEHA is not classifiable as a human carcinogen. It is
grouped as a category 3 carcinogen: Limited evidence of carcinogenicity in
animals (IARC, 2000).
In the available literature DEHA has been shown to cause a
significantly increased incidence of liver tumours in female mice and a
non-significantly increased incidence in male mice (a 2-year study), and
that changes in liver biochemistry has been observed in rats (among other
changes in cytochrome P450) (European Commission Joint Research centre,
1996). Liver tumours are proposed to be induced by peroxisome
proliferation through a mecha-nism which involves hormone receptors
expressed at a much lower level in human liver than in mice (CSTEE,
1999).
Reproductive and developmental toxicity is investigated in a number of
studies. In the available literature the lowest maternal toxicity was
observed at a level of 170 mg/kg bw/day in rats. A NOAEL of 28 mg/kg
bw/day for foetal toxicity resulting in skeletal variations, kinked or
dilated ureters was established in a rat study following the OECD 414
guideline (BUA, 1996a). The Scientific Committee for Food has established
a NOAEL for foetotoxicity at 30 mg/kg bw/day (CSTEE 1999).
NOAEL/LOAEL
The lowest reported NOAEL in the reviewed literature is this NOAEL of
28 mg/kg bw/day for foetal toxicity in rats, which must be considered the
most sensitive effect. The most critical effect of the structural analogue
DEHP, namely testicular toxicity (KemI, 2000), has not been addressed for
DEHA in the reviewed literature.
Toxicokinetic
The main metabolite in human blood is 2-ethylhexanoic acid. Its
elimination half time was found to be 1.65 hrs. In urine the observed
metabolites were 2- ethylhexanoic acid (8.6%), 2-ethyl-5-hydrohexanoic
acid (2.6%) 2-ethyl-1,6-hexanedoic acid (0.7%), 2-ethyl-5-ketohexanoic
acid (0.2%) and 2-ethylhexanol (0.1%). The elimination half time was
approx. 1.5 hours. After 36 hrs no metabolites were detected in the urine
(HSDB, 2000).
Summation/Conclusion
Based on the available literature DEHA has been shown be of low acute
toxicity and to cause slight irritation to rabbit skin and eyes in some
studies. DEHA has not shown a skin sensitisation potential in the reviewed
literature.
In reproductive toxicity studies DEHA has shown to produce foetal
toxicity in rats. A NOAEL of 28 mg/kg bw /day was established (BUA, 1996).
DEHA is reported to cause liver tumours in mice. CSTEE (1999) proposes
that liver tumours are induced by peroxisome proliferation through a
mechanism which involves hormone receptors expressed at a much lower level
in human liver than in mice.
According to IARC, DEHA is not classifiable as a human carcinogen and
it is classified as a category 3 carcinogen: Limited evidence of
carcinogenicity in animals. This conclusion has been drawn by a working
group re-evaluating the evidence for carcinogenicity for 16 industrial
chemicals, reported in the IARC Monograph, Volume 77. DEHA causes
peroxisome proliferation in the liver in mice and rats, but evidence that
this compound is carcinogenic in experimental animals is less than
sufficient. Considerations of mechanism or mode of action of DEHA
therefore played no role in the classification by the working group. In
relation to the structural analogue, DEHP, the working group has concluded
that the mechanism by which DEHP increases the incidence of hepatocellular
tumours in rats and mice is not relevant to humans. DEHP produces liver
tumours in rats and mice by a non-DNA-reactive mechanism involving
peroxisome proliferation, which has not been demonstrated in human
hepatocyte cultures or exposed non-human primates. (IARC, 2000).
The mutagenicity of DEHA is weak.
An ADI on 0.3 mg/kg bw/day for DEHA has been estimated by the EU´s
Scientific Committee for Food (SCF, 2000). This value is far above the
results from the EASE calculation. It is therefor estimated that the
selected scenario will not contribute to the daily human intake of DEHA in
a significant amount.
Critical effect
The identified critical effect of DEHA in a
developmental study is foetotoxicity. The established NOAEL is 28 mg/kg
bw/day.
Classification
Based on the available data, the only observed effect which
could result in classification according to the criteria in the EU
Substance directive (EEC 1967) is foetal toxicity in rats. This would,
however, require more detailed information.
Exposure versus toxicity
A comparison between the calculated
exposure of consumers and the available toxicological information about
DEHA indicates that the selected exposure scenario regarding floor and
wall coverings represents a minor risk to human health. DEHA is however
widely used, and when other possible sources of exposure are taken into
consideration, the total load of DEHA may reach the same order of
magnitude as the established ADI.
Comparing the estimated daily exposure to DEHA from haemodialysis to
estimated daily exposure in a similar scenario for DEHP shows that the
average daily exposure of 2.9 - 72m g/kg
bw/day for DEHA is 50 - 1000 times lower than for DEHP, which is
considered more toxic than DEHA. For comparison the lowest LD50 for
DEHP administered intravenously to rats and reported in the reviewed
literature is 250 mg/kg bw. It should be mentioned that this study is
reported to be inappropriate for a risk assessment due to poor design
and/or reporting (KemI 2000). The LD50 for DEHA administered
intravenously to rats and reported in the reviewed literature is 900 mg/kg
bw and 540 mg/kg bw in rabbits. The NOAEL for the critical foetotoxic
effect of DEHA to rats is approximately 0.4
103 - 10 103 times
higher than the estimated average daily exposure from haemodialysis.
Possible adverse effects have been observed in humans following
inhalation of concentrations of 11.7m g/m3
to 14.6m g/m3. As the
selected workplace scenario in EASE results in concentration levels 104
times bigger, similar or more severe effects can be expected, even though
the EASE calculation must be considered rather conservative.
Based on the available data the milk tube scenario may indicate that if
a child with a weight of 10 kg drinks 1 l of milk pr. day the maximum dose
will be 0.05 mg/kg bw. As the ADI is 0.3 mg/kg/bw, the maximum dose is 17%
of the ADI.
Generally, data on the environmental effects from DEHA are available,
especially from the acute aquatic test systems. In the following the most
sensitive data is presented.
Table 5.7 Ecotoxicity and fate data on DEHA
|
Aquatic (mg/l) |
Microorganisms |
Terrestrial |
Bioaccumulation |
Biodegradation (%) |
|
Algae |
Crustaceans |
Fish |
mg/l |
|
BCF |
Aerobic |
Anaerobic |
Acute |
> 100 x Sw
(96 h) |
0.66 |
> 100 x Sw |
>10,000 |
N.D. |
27 |
66
(ready) |
N.D. |
Chronic |
N.D. |
0.035-0.052
(MATC)* |
N.D. |
N.D. |
N.D. |
- |
- |
- |
N.D.: No data found
-: Not relevant for the specific parameter.
*: Maximum acceptable toxicant concentration
Acute toxicity
DEHA is not toxic to algae at or below the water solubility level of
DEHA (0.78 mg/l). It should be noted that the test duration in this test
was 96 hours, a day longer than standard acute tests for algae (Felder et
al., 1986).
A number of acute studies in algae, crustaceans and fish observed
toxicity at concentrations above the solubility of DEHA in water (BUA,
1996a; European Commission Joint Research Centre, 2000). However, the
acute toxicity for D. magna is shown to be 0.66 mg/l in one study
performed with low concentrations (Felder et al., 1986), and DEHA is
therefore considered very toxic to crustaceans.
Chronic toxicity
The chronic data for crustaceans shows that in a 21d flow through test
DEHA had adverse effects on the reproduction of Daphnia magna. The
maximum acceptable toxicant concentration (MATC) for reproduction (and
body length and mortality) ranged from 0.035 to 0.052 mg/l (Felder et al.,
1986).
Microorganisms and terrestrial ecotoxicity
DEHA does not seem to have any apparent effects on microorganisms in
environmentally relevant concentrations. No data on terrestrial organisms
was found.
Bioaccumulation
DEHA has a measured bioaccumulation factor of 27 (Felder et al., 1986)
showing that DEHA is not a bioaccumulative substance. There is a
discrepancy between the measured and the estimated bioaccumulation, the
estimated value being 100 fold higher than the actual measured BCF, which
indicate that DEHA is not bioaccumulated as predicted by directly LogPow.
This is common for very lipophilic substances.
Aerobic and anaerobic biodegradation
According to the available data there is evidence of ready
biodegradability of DEHA (BUA 1996a), but no data are available on
inherent or anaerobic biodegradation. A simple mass balance of DEHA on
three sewage treatment plants in Denmark (Hoffmann 1996), shows that a 90%
reduction is achieved in the plants. However, also that between 15 and 25%
of the DEHA plasticiser in the inflow is later found in the sludge, which
is comparable to the fate of DEHP.
Environmental assessment
Most of the data on algae, crustacean and fish are reported as ‘>
water solubility’. For the purpose of the environmental assessment these
values are evaluated according to Pedersen et al. (1995) and the 50%
effect concentration set equal to the water solubility. The lowest
observed acute LC50 was identified for Daphnia magna for
the aquatic environment. For this species a chronic test (reproduction
test) result was also found. The endpoint in the reproduction test was
MATC, which may be a accepted as a NOEC, and the assessment factor for
derivation of PNEC is 100 according to the EU TGD 1996 (three acute and
one chronic results). The estimated PNEC is 0.00035 mg/l.
If the chronic test result is not considered as a NOEC, an assessment
factor of 1,000 based on the acute test results in a PNEC of 0.00066 mg/l.
The most conservative result is obtained using the MATC result, and this
is used in assessment presented below. The additional factor of 10 is
applied for very lipophilic substances to allow for additional intake via
food in benthic organisms (EU TGD 1996).
Table 5.8 Environmental Assessment for DEHA
Scenario |
Aquatic |
|
|
Surfacet |
Sediment |
Estimation |
|
|
Aquatic |
0.092 |
0.4a |
Worst case |
|
|
Aquatic |
0.583 |
2.2a |
a including additional factor 10 due to high lipophilicity (LogPow
> 5)
Conclusion
Under worst case assumptions the PEC/PNEC ratio exceeds 1 in the
sediment compartment, thus predicting potential effects to organisms
living here. In all other cases the aquatic PEC do not exceed the PNEC. A
terrestrial risk assessment cannot be performed due to lack of toxicity
data.
Physical-chemical properties
Citrates are esters of citric acid and these plasticisers are produced
with a variety of alcohol groups.
O-acetyl tributyl citrate (ATBC) is a relatively water-soluble
plasticiser with measured data ranging from insoluble to 0.005 g/l measured
at an unknown temperature. ATBC has an estimated vapour pressure of 4.6
10-6 mm Hg. The estimated LogPow value of 4.3 (HSDB
2000) indicates that this substance is less lipophilic compared to
phthalates and many other plasticisers.
Migration
The measured reduced migration potential (household cling to olive oil
and acetic acid) of 2.8-4.7 mg/dm2 indicates that ATBC possesses
the potential of migrating from the cling phase to a fatty or aqueous phase
in contact with the cling (Plastindustrien i Danmark 1996). The migration is
faster, when the receiving phase contains fat. The loss from film to food
(cheese) corresponds to 1-6% of the plasticiser in the film (Castle et al.,
1988b). ATBC migrates less than diisononyl phthalate (DINP) in a saliva
simulant test (Nikiforov, 1999).
Use pattern for compound
The main uses of acetyl tributyl citrate may be in products used in toys,
the hospital sector, packaging, printing inks, adhesives, fillers and
products containing various amounts of plastic material, cf. Table 4.6.
Exposure in the work place
The EASE calculation focuses on the production and use of printing inks
in printed magazines.
The following assumptions are made with regard to the workplace exposure:
- production takes place at a temperature of max. 30 ºC
- required legal exhaust ventilation is in place
- contact with the substance will only take place incidentally, e.g. in
relation to cleaning and maintenance of production equipment.
Possible main exposure routes in the workplace is:
Based on this scenario, the EASE calculation gives the results shown in
Table 5.9.
Table 5.9 Estimated values of ATBC in the working
environment according to the EASE calculation
Route of exposure |
EASE value |
Unit |
Vapour concentration in air for workers |
0.5-3 |
ppm |
Vapour concentration in air for workers |
8.37-50.2 |
mg/m3 |
Potential dermal uptake for workers |
0 |
mg/kg/day |
Consumer exposure
Two scenarios have been selected for evaluation of consumer exposure to
ABTC: a limited exposure from plasticiser use in printing inks and an exposure
of a vulnerable group – infants chewing on a teething ring.
Printing ink
The selected scenario is the exposure of an adult half an hour a day
reading a printed magazine. Based on this scenario, the EASE calculation gives
the results shown in Table 5.10.
Table 5.10 Estimated potential daily intake of ATBC by consumers according to the EASE
calculation
Route of exposure |
Daily intake in mg/kg bw/day |
Ratio of the ADI |
Inhalatory intake |
5.82 x 10-6 |
* |
Dermal uptake |
8.04 x 10-13 |
* |
Oral intake |
0 |
* |
Total chronic uptake via different routes |
4.36 x 10-6 |
* |
Total acute uptake via different routes |
0 |
* |
*: The ADI has not been established. An estimated ADI of 1 mg/kg bw/d is
calculated in Nikiforov (1999)
Teething ring
A special EASE-scenario has been set up for the use of ATBC in teething
rings used by small children. It is assumed that use occurs 3 hours pr day (10
events of 20 minutes each). In the scenario, uptake through the mucous
membranes in the gums is not considered as the absorption rate is unknown. The
result of the EASE-calculation is shown in Table 5.11.
Table 5.11 Estimated potential daily intake of ATBC by contact with toys by consumers
according to the EASE calculation
Route of exposure |
Daily intake in mg/kg bw/day |
Ratio of the ADI |
Inhalatory intake |
3.85 x 10-10 |
* |
Dermal uptake |
0.06 |
* |
Oral intake |
0 |
* |
Total chronic uptake via different routes |
0.06 |
* |
Total acute uptake via different routes |
0 |
* |
*: The ADI has not been established. An estimated ADI of 1 mg/kg bw/d is
calculated in Nikiforov (1999).
The EASE calculation does not take exposure via mucous membranes into
consideration nor swallowing of saliva. An estimated total oral intake from
mouthing of plasticised toys must therefore be expected to be higher. However,
for ATBC a preliminary risk characterisation has been carried out on behalf of
the producer (Nikiforov, 1999) based on American and Dutch risk
characterisations for DINP. Considering that migration of ATBC was approx. one
third of DINP under identical conditions, an expected daily intake (EDI) after
mouthing 11 cm2 of surrogate toy for four 15 minutes periods
amounts to an average of 0.006 mg/kg bw/day and 0.094 mg/kg bw/day for the 95th
percentile. These results apply to infants 3-12 months old and assuming all
plasticiser in saliva is bioavailable.
In the EASE scenario the exposure time is considerably higher (200 minutes
compared to 60 minutes). Adjustment for this yields 0.31 mg/kg bw/day and
adding the 0.06 mg/kg bw/day results in a total EDI of 0.37 mg/kg bw/day. An
estimated ADI of 1 mg/kg bw/d is calculated in Nikiforov (1999).
Environmental exposure of humans
The amount established in ’Usage’ section is used to calculate exposure
for a number of environmental compartments by EU TGD/EUSES.
Table 5.12 The estimated human doses of ATBC through intake of water, fish, leaf of
crops, roots of crops, meat, milk and air.
ATBC |
|
Estimation (~ 550 t) |
Worst case (10,700 t) |
|
|
mg/kg/d |
mg/kg/d |
Drinking water |
|
2.9 10-6 |
8.5 10-6 |
Fish |
BCF estimated* |
0.00031 |
0.0009 |
Plants |
Leaf crops |
0.000006 |
0.000106 |
|
Root crops |
2 10-6 |
8 10-6 |
Meat |
|
7 10-8 |
9.6 10-7 |
Milk |
|
4 10-8 |
5.7 10-7 |
Air |
|
2 10-8 |
3.6 10-7 |
Total regional |
|
0.00031 |
0.00102 |
* Measured BCF value not available
Exposure in the environment
The estimated concentration levels of ATBC indicate a high concentration in
the particulate phases (sediment and soils).
Table 5.13 The estimated regional concentrations of ATBC in water, soil and air.
Compartment |
Aquatic |
Terrestrial |
Air |
ATBC |
Surfacet |
Surfaced |
Sediment |
Natural |
Agricultural |
Porewater of agri. soil. |
Industrial |
|
|
mg/l |
mg/l |
mg/kg |
mg/kg |
mg/kg |
mg/l |
mg/kg |
mg/m3 |
Estimation (~ 550 t) |
0.0002 |
0.0002 |
0.027 |
0.00002 |
0.00018 |
2.3 10-6 |
0.00096 |
1 10-7 |
Worst case |
0.0006 |
0.0006 |
0.078 |
0.00034 |
0.00060 |
7.7 10-6 |
0.0186 |
1.7 10-6 |
Secondary poisoning
Only estimated BCF values are available. These lead to relatively high
concentrations in fish.
Table 5.14 The estimated regional concentrations of ATBC in fish, plants, meat and
milk.
Articles of food |
Wet fish |
Plants |
Meat |
Milk |
ATBC |
Estimate |
Measured |
Roots |
Leaves |
Grass |
|
|
|
mg/kg |
mg/kg |
mg/kg |
mg/kg |
mg/kgww |
mg/kgww |
mg/kgww |
Estimation (~ 550 t) |
0.19 |
N/A. |
0.0004 |
0.0004 |
0.0004 |
0.00002 |
4.9 10-6 |
Worst case (10,700 t) |
0.55 |
N/A. |
0.0014 |
0.0062 |
0.0062 |
0.00022 |
7.08 10-5 |
N/A.- not available. Data needed to perform estimation of BCF not
available.
The most significant toxicity data on ATBC are presented in Table 5.15.
Table 5.15 Selected toxicity data on ATBC
Toxicology |
Species |
Protocol |
Dose levels / duration |
Results |
Ref. |
Acute oral toxicity |
Rat |
N.D. |
|
LD50=31.4 g/kg bw |
1 |
Acute inhalation toxicity |
- |
|
|
|
|
Acute dermal toxicity |
- |
|
|
|
|
Acute toxicity, other routes |
Rabbit |
N.D. |
0.1 g/kg bw (i.v.) |
Increased motor activity and respiration. |
3
|
|
Rabbit |
N.D. |
Unspecified dose (i.v.) |
Depressive effect on blood pressure and respiration. |
3 |
|
Mouse and rat |
N.D. |
0.4 g/kg bw (i.p.) |
Severe signs of CNS toxicity. |
3 |
Irritation
- skin |
Rabbit
|
N.D. |
N.D. |
Not irritating. |
4 |
- eye |
Rabbit
Rat |
N.D.
N.D. |
5%
N.D. |
Temporarily abolished corneal reflex action
Moderate irritation. |
3
4 |
Sensitisation |
Guinea pig |
Maximisation test |
N.D. |
Not sensitising |
4 |
Repeated dose toxicity |
Rat, Wistar |
Repeated oral dose, OECD 408 |
100, 300, 1000 mg/kg bw/day
90 days |
Haematological and biochemical changes. Increased liver weight at top
dose.
NOAEL = 100 mg/kg bw/day. |
4
|
Genetic toxicity |
Salmonella typhimurium |
Ames test, +/-
|
N.D. |
Not mutagenic |
2 |
|
Rat lymphocytes |
+/- |
N.D. |
No chromosomal aberrations |
4 |
|
Rats |
Unscheduled DNA synthesis |
800, 2000 mg/kg, gavage |
No UDS |
4 |
Reproductive / developmental toxicity |
Rat, Sprague Dawley |
2-generation reproduction, OECD 416
|
0, 100, 300, 1000 mg/kg/day
|
Decreased bodyweights
NOAEL = 100 mg/kg bw/day |
4 |
Carcinogeni-city |
Rat, Sherman |
N.D. Old guideline. Feeding study |
0, 200, 2000, 20000 ppm.
2 years |
No significant exposure related findings. Results cannot be evaluated
(old guideline). |
4 |
Experience with human exposure |
Human |
Sensitisation test |
N.D. |
No sensitisation or irritation. |
4 |
References: 1) HSDB (2000), 2) CCRIS (2000), 3) TNO BIBRA International Ltd
(1989), 4) CSTEE (1999)
Observations in humans
There was no evidence of irritation or sensitisation in a sensitisation
test in humans. No further information is available.
Acute and chronic toxicity
Acetyl tributyl citrate has exhibited low acute oral toxicity in laboratory
animals (LD50=31.4 g/kg) (HSDB, 2000).
Studies where a single dose (0.1 - 0.4 g/kg bw) of ATCB has been
administered by the intraperitoneal or intravenous route have indicated that
the central nervous system and blood are the critical organs in various
species (rodents) of laboratory animals (TNO BIBRA, 1989).
Irritation
Available data indicate no irritation of skin and moderate eye irritation
(CSTEE, 1999; TNO BIBRA, 1989).
Sensitisation
O-acetyl tributyl citrate was not sensitising in a guinea pig maximisation
test (CSTEE, 1999).
Repeated dose toxicity
A NOAEL of 100 mg/kg bw/day was established in a 90 gavage study in rats
where haematological and biochemical changes and increased liver weights
were observed at higher doses (CSTEE, 1999).
Genetic toxicity
Acetyl tributyl citrate has not been shown to be mutagenic in the reported
Ames bacterial assay. ATCB did not cause chromosomal aberrations in rat
lymphocytes or unscheduled DNA synthesis in rats treated by gavage at 800
or 2,000 mg/kg bw. The negative UDS study indicated that the in vivo
genotoxic potential of ATCB is low or absent (CSTEE 1999).
Long term toxicity
In a two-year carcinogenicity study, rats were fed doses of 200; 2,000 and
20,000 ppm ATBC in the diet. No significant dose related toxicological
findings were reported. The study is however not according to modern
guidelines and the carcinogenicity of ATBC cannot be evaluated properly
based on these findings (CSTEE, 1999).
In a two-generation reproduction study in rats according to OECD
guideline 416, rats were fed doses of 100, 300 and 1,000 mg/kg bw/day.
Decreased body weights in F1 males from 300 mg/kg bw/day and F0 males at
1000 mg/kg bw/day were observed. A NOAEL of 100 mg/kg bw/day was
estab-lished (CSTEE, 1999).
NOAEL/LOAEL
Lowest reported NOAEL is 100 mg/kg bw/day (repeated dose 90 days oral
toxicity in rats and reproductive toxicity rats) (CSTEE, 1999).
Summation/Conclusion on health
Sufficient data were not found to make a profound health assessment.
ATCB has very low acute toxicity. LD50 in rats was reported to
be 31.4 g/kg bw.
O-acetyl tributyl citrate was not found to be an irritant to skin or
sensitising. Moderate eye irritation has been observed. (CSTEE, 1999; TNO
BIBRA, 1989).
In the reviewed literature o-acetyl tributyl citrate has not been found
mutagenic. ATCB did not cause chromosomal aberrations in rat lymphocytes or
unscheduled DNA synthesis in rats treated by gavage. The negative UDS study
indicated that the in vivo genotoxic potential of ATCB is low or absent
(CCRIS, 2000; CSTEE, 1999)
Repeated dose toxicity in rats included haematological and biochemical
changes and increased liver weights. A NOAEL of 100 mg/kg bw/day was
established (CSTEE, 1999).
The carcinogenic potential cannot be evaluated based on the available
literature.
Decreased body weights were observed in F1 male rats (300 mg/kg bw/day) and
F0 male rats (1,000 mg/kg bw/day) in a 2-generation study. A NOAEL of 100
mg/kg bw/day was established.
Critical effect
Based on the available limited data, the
identified critical effect in rats appears to be reproductive toxicity
resulting in decreased body weights and repeated dose toxicity resulting in
haematological and biochemical changes and increased liver weights.
Classification
Sufficient data are not available to evaluate the classification of the
substance for all effects.
Exposure versus toxicity
A comparison between the calculated exposure
of consumers and the very limited available toxicological information about
ATBC indicates that the selected exposure scenario represents a minor risk to
human health.
General exposure of the population may occur through dermal contact with
consumer products containing O-acetyl tributyl citrate and ingestion of
contaminated food. O-acetyl tributyl citrate has been found in the aquatic
environment.
The selected scenario for EASE-calculation of the consumer exposure of
o-acetyl tributyl citrate results in low exposures. It is therefore estimated
that only a limited contribution of the overall exposure of humans comes from
products.
No ADI has been established for ATBC. A preliminary ADI has been estimated
to 1 mg/kg bw/day (Nikiforov 1999). An ADI of 0.05 mg/kg bw/day may be
assigned on a conservative basis from DEHP proliferation peroxisome data, but
it should be mentioned that there is no information in the available
literature indicating that ATBC causes peroxisome proliferation.
The selected EASE-scenario for teething rings modelling the exposure of
o-acetyl tributyl citrate in children from dermal contact is 6% of a
preliminary ADI and similar to the assigned ADI. It should, however, be
mentioned that the EASE scenario of exposure to ATCB from toys does not
adequately model the oral exposure from plasticisers in teething rings since
swallowing of saliva and uptake via the mucous membranes is not included. A
different approach including these sources yields seven times the assigned ADI
and 37% of the preliminary ADI for infants.
By the oral route, ATBC exhibits low acute toxicity in laboratory animals,
but no data have been found describing toxicity by inhalation or dermal
toxicity.
With regard to exposure in the working environment, relevant data have not
been identified. Exposure may occur through inhalation of dust particles and
dermal contact when working in places where O-acetyl tributyl citrate is
handled.
The EASE-calculation indicates that the concentration of o-acetyl tributyl
citrate in the working environment of the selected scenario can be in
quantities of up to 50 mg/m3. Due to the lack of toxicity data, it
is not possible to assess whether this value gives rise to concern.
Very few ecotoxicity data was found for ATBC. Biodegradation data has been
identified.
Table 5.16 Ecotoxicity and fate data on ATBC.
ATBC |
Aquatic
(mg/l) |
|
|
|
Terrestrial |
Bioaccumulation |
Biodegradation |
|
|
Algae |
Crustaceans |
Fish |
Microorganisms |
|
|
Aerobic |
Anaerobic |
|
|
|
|
|
|
BCF |
28 days |
|
Acute |
N.D. |
N.D. |
38-60 |
N.D. |
N.D. |
1,100
(estimated) |
80% at 30 mg/l
(inherent) |
N.D. |
Chronic |
N.D. |
N.D. |
N.D. |
N.D. |
N.D. |
- |
- |
- |
Aquatic and terrestrial ecotoxicity
The only ecotoxicological data identified for ATCB originates in
volunteered proprietary information. Two species of typical freshwater test
species showed LC50’s ranging from 38-60 and 59 mg/l,
respectively (Ecosystems Laboratory 1974). No chronic ecotoxicological data
was found.
Bioaccumulation
The estimated BCF indicate that ATBC can be bioaccumulated (Syracuse
Research Corporation, 2000). An estimated LogPow value on 4.3
supports this assumption.
Aerobic and anaerobic biodegradation
Aerobic biodegradation in non-standard test showed a rather slow
degradation 26% after 21 days (Ecosystems Laboratory 1974). No data on
anaerobic biodegradation was found.
ATBC was degraded 80% in an inherent biodegradation test. The compound is
therefore assessed as inherently biodegradable.
Risk assessment
The data available is insufficient for calculating a PNEC according to the
EU TGD. If however, a PNEC is based on the single study available a PNEC of
approx. 0.04 mg/l is estimated for the aqueous phase, the predicted
concentrations (PECs) for surface water and for sediment are 50-500 times
lower than PNEC.
Table 5.17 Risk Assessment on ATBC (based on incomplete data set).
Risk assessment |
Aquatic |
|
|
Surfacet |
Sediment |
Best guess |
|
|
Aquatic |
0.005 |
0.002 |
Worst case |
|
|
Aquatic |
0.015 |
0.005 |
Based on the relatively slow degradation and lipophilicity of ATBC it is
assumed that effects in the environment may be associated with the potential
for bioaccumulation in fauna in the receiving environment.
Physical-chemical
The water solubility of di(2-ethylhexyl) phosphate (DEHPA) has been
measured to 100 mg/l at an unknown temperature. Under the assumption
that the solubility was measured at standard temperature, DEHPA is a
relatively soluble compound when compared to the other substances
investigated.
This substance is an acid with a pKa in the range of 1.72-2.17,
which indicates that this compound is fully dissociated at neutral pH.
DEHPA has an estimated vapour pressure of 4.65
10-8 mm Hg. Under the assumption that the estimated vapour pressure
is valid at standard temperature, the magnitude of the vapour pressure places
DEHPA among the substances investigated that possess a very low vapour
pressure.
The measured LogPow value of 2.67 indicates that this substance
is moderately lipophilic agrees with low BCF values (BUA 1996b). The estimated
LogPow value of 6.07 presumably overestimates lipophilicity due to
the presence of the dissociable phosphate group. Under the assumption that the
measured Pow is valid in natural pH range, DEHPA possess low
lipophilicity when compared to the other substances investigated. This
substance is also an acid with a pKa in the range of 1.72-2.12,
which indicates that this compound is almost completely dissociated at pH 5-9
(BUA, 1996b).
Migration
No information on the migration potential of DEHPA has been located.
Migration of diphenyl 2-ethylhexyl phosphate from food films ranged from
0.1-0.5 mg/dm2 when measured in a range of fat containing food
products (Castle et al, 1988b).
The group of phosphate plasticisers are triesters of phosphoric acid and
includes triaryl and trialkylesters. This group of plasticisers is more
resistant to ignition and burning than all the other groups of ester
plasticisers and is most often used as flame-retardants in products with
specific fire resistant demands.
Use pattern for compound
The main uses of DEHPA may be in PVC-products used in e.g. the hospital
sector, packing, cables, profiles and floor and wall coverings, cf Table 4.6.
Exposure in the work place
The EASE-calculation focuses on the production of cables.
The following assumptions are made with regard to the workplace exposure:
- production takes place at a temperature of 180 °ºC
- required legal exhaust ventilation is in place
- contact with the substance will only take place incidentally, e.g. in
relation to cleaning and maintenance of production equipment.
Possible main exposure routes in the workplace:
Based on this scenario, the EASE calculation provides the results shown in
Table 5.18.
Table 5.18 Estimated values of DEHPA in the working environment according to the EASE
calculation.
Route of exposure |
EASE value |
Unit |
Vapour concentration in air for workers |
0-0.1 |
ppm |
Vapour concentration in air for workers |
0-1.34 |
mg/m3 |
Potential dermal uptake for workers |
0 |
mg/kg/day |
Consumer exposure
The EASE-calculation focuses on use of cables in a normal private house.
Possible main routes of consumer exposure:
- inhalation
- dermal contact with consumer goods
- ingestion of contaminated food.
Based on this scenario, the EASE calculation gives the results shown in
Table 5.19.
Table 5.19 The estimated potential daily intake of DEHPA by consumer according to the
EASE calculation
Route of exposure |
Daily intake in mg/kg bw/day |
Ratio of the ADI |
Inhalatory intake |
5.82 x 10-6 |
* |
Dermal uptake |
8.04 x 10-13 |
* |
Oral intake |
0 |
* |
Total chronic uptake via different routes |
4.36 x 10-6 |
* |
Total acute uptake via different routes |
0 |
* |
*: The ADI has not been established. Other phosphorous acid dialkyl esters
have been allocated a group restriction value of 0.05 mg/kg bw/d based on DEHP
peroxisome proliferation data (SCF, 2000).
Environmental exposure of humans
The EUSES-calculation indicates that humans may by exposed for the
substance as illustrated in Table 5.20.
Table 5.20 The estimated human doses of DEHPA through intake of water, fish, leaf of
crops, roots of crops, meat, milk and air.
DEHPA |
|
Estimation (~ 2,000 t) |
Worst case (10,700 t) |
|
|
mg/kg/d |
mg/kg/d |
Drinking water |
|
1.1 x 10-5 |
5.7 x 10-5 |
Fish |
BCF measured |
3.7 x 10-6 |
2.0 x 10-5 |
Plants |
Leaf crops |
1.3 x 10-5 |
6.9 x 10-5 |
|
Root crops |
2.1 x 10-6 |
1.1 x 10-5 |
Meat |
|
3.7 x 10-9 |
1.9 x 10-8 |
Milk |
|
4.6 x 10-9 |
2.4 x 10-8 |
Air |
|
4.4 x 10-9 |
2.3 x 10-8 |
Total regional |
|
0.00003 |
0.00016 |
Exposure in the environment
The estimated concentration levels of DEHPA show that concentrations in the
aqueous compartment are relatively high compared to other plasticisers due to
the high solubility of DEHPA.
Table 5.21 The estimated regional concentrations of DEHPA in water, soil and air.
Compartment |
Aquatic |
|
|
Terrestrial |
|
|
|
Air |
DEHPA |
Surfacet |
Surfaced |
Sediment |
Natural |
Agricultural |
Porewater of agri. soil. |
Industrial |
|
|
mg/l |
mg/l |
mg/kg |
mg/kg |
mg/kg |
mg/l |
mg/kg |
mg/m3 |
Estimation (~ 2,000 t) |
0.0004 |
0.0004 |
0.0017 |
0.0005 |
0.0003 |
6.6 x 10-5 |
0.0049 |
2.1 x 10-8 |
Worst case (10,700 t) |
0.0020 |
0.0020 |
0.0090 |
0.0026 |
0.0013 |
3.5 x 10-4 |
0.0256 |
1.1 x 10-7 |
Secondary poisoning
DEHPA is not expected to bioaccumulate and there is no anticipation of
secondary poisoning.
Table 5.22 The estimated regional concentrations of DEHPA in fish, plants,
meat and milk.
Articles of food |
Wet fish |
Plants |
|
|
Meat |
Milk |
DEHPA |
estimate |
measured |
Roots |
Leaves |
Grass |
|
|
|
mg/kg |
mg/kg |
mg/kg |
mg/kg |
mg/kgww |
mg/kgww |
mg/kgww |
Estimation (~ 2,000 t) |
0.014 |
0.002 |
0.0004 |
0.0008 |
0.0008 |
9 10-7 |
6 10-7 |
Worst case (10,700 t) |
0.073 |
0.011 |
0.0020 |
0.0040 |
0.0040 |
4.8 10-6 |
3.0 10-6 |
The most significant toxicity data on DEHPA are presented in Table 5.23.
Table 5.23 Selected toxicity data on DEHPA.
Toxicology |
Species |
Protocol |
Dose levels / duration |
Results |
Ref. |
Acute oral toxicity |
Rat |
N.D. |
|
LD50=4,742 mg/kg bw |
2 |
Acute inhalation toxicity |
Dogs |
N.D. |
380 ppm, 8 hours |
Death occurred (no further info) |
2 |
Acute dermal toxicity |
Rabbit |
N.D. |
1.25 ml/kg, 24 hours |
LD50=1,200 mg/kg bw |
2 |
Acute toxicity, other routes |
Rat |
N.D. |
i.p. |
LD50=50-100 mg/kg bw |
2 |
Irritation
- skin |
Rabbit
|
Occlusive test, intact skin |
10m l (24 hours) |
Necrosis after 24 hours |
2 |
- eye |
Rabbit |
N.D. |
5m l (1%) |
Corrosive to cornea |
2 |
Sensitisation |
- |
|
|
|
|
Repeated dose toxicity |
Rat (Sprague Dawley) |
|
25, 100, 200 mg/kg bw (5 days) |
Significant increased in relative liver weights at 100 and 200 mg/kg
bw/day. Potent induction of P450b+e system. |
2 |
Genetic toxicity |
Salmonella typhimurium |
Ames test, +/-
|
4-2,500m g/plate (cytotoxic from 100
g/plate) |
Not mutagenic |
2 |
Reproductive / developmental toxicity |
- |
|
|
|
|
Carcinogencity |
- |
|
|
|
|
Experience with human exposure |
Human |
Irritation test |
N.D. |
Smarting of skin and 1st degree burn |
1 |
|
Human |
Inhalation |
2 ppm |
Weakness, irritability and headache |
1
|
References: 1) HSDB (2000), 2) BUA (1996b)
Observations in humans
Inhalation of 2 ppm showed weakness, irritability and headache.
DEHPA caused irritation of eyes and first and second degree skin burns.
Acute and chronic toxicity
An oral LD50 in rats of 4,742 mg/kg is reported representing
low acute toxicity. The observed dermal LD50 leads to classification with R21 (Harmful
in contact with skin).
Irritation/corrosion
The substance is reported to corrosive to skin and eyes in rabbits.
Sensitisation
No information is available on skin sensitisation.
A repeated dose toxicity study in rats dosed for five days showed a
signifi-cant increase in relative liver weights at 100 and 200 mg/kg bw and
induction of the P450b+e system.
Genetic toxicity
DEHPA has not been shown to be mutagenic (BUA 1996b).
Long term toxicity
Concerning reproductive and teratogenic effects of DEHPA, relevant data
have not been identified.
NOAEL/LOAEL
Relevant data have not been identified in the investigation.
Summation/Conclusion on health
Sufficient data were not found to make a profound health assessment.
However, inhalation of 2 ppm caused weakness, irritability and headache in
humans.
Acute oral toxicity of di(2-ethylhexyl) phosphate to rats seems to be low,
whereas dermal toxicity to rabbits is pronounced.
Di(2-ethylhexyl) phosphate exhibits strong corrosive effect in cornea at 5m
l doses (1% solution) as well as corrosive effects on rabbit skin. Mutagenic
activity has not been observed.
Data establishing reproductive toxicity or teratogenicity were not found.
Critical effect
All endpoints have not been sufficiently investigated. Dermal toxicity
and local corrosive effects on skin and eyes observed in rabbits seem to be
the most severe effects.
Classification
Sufficient data are not available for classification. DEHPA has been
classified by Bayer AG in 1993 as C (Corrosive); R34 (Causes burns)
and Xn (Harmful); R21 (Harmful in contact with skin).
Exposure versus toxicity
A comparison between the calculated exposure of consumers and the
available toxicological information about DEHPA indicates that the selected
exposure scenario represents a minor risk to human health. This is based on
calculated exposure values several orders of magnitude lower than the observed
effect levels in animal studies.
General exposure of the population may occur through dermal contact with
consumer products containing di(2-ethylhexyl) phosphate and ingestion of
contaminated food.
Based on the selected scenario, the EASE-calculation indicates that the
exposure of di(2-ethylhexyl) phosphate in consumers represents very small
values and constitutes a limited contribution to the overall exposure of
consumers.
The values are at the same level or below the values arising from the
indirect exposure by contaminated food.
Concerning exposure in the working environment, inhalation of 2 ppm has
been observed to cause weakness, irritability and headache. Exposure may occur
through inhalation of dust particles and dermal contact when working in places
where di(2-ethylhexyl) phosphate is handled.
The EASE-calculation indicates that the concentration of di(2-ethylhexyl)
phosphate in the working environment related to the selected scenario can be
in quantities up to 0.1 ppm. This value is only a factor 20 from the
concentration that may cause adverse effects from inhalation.
Aquatic and terrestrial ecotoxicity
The ecotoxicological data from acute standard tests indicate, that
di(2-ethylhexyl) phosphate is harmful to algae (BUA 1996b), crustaceans (US
EPA 2000) and fish (BUA 1996b), i.e. the L(E)C50’s are in the
10-100 mg/l range. Slightly increased acute toxicity is, not surprisingly,
seen in the tests of longer duration. Data from true chronic tests are not
available, but growth inhibition is reported down to 0.3 mg/l in fish and
microorganisms (HSDB 2000). The nature of the tests has not been identified.
The respiration of the micro-organism Thiobacillus ferrooxidans was
inhibited 68% in a three hours test (BUA 1996b). No data on terrestrial
ecotoxicity was identified.
Table 5.24 Ecotoxicity and fate data on DEHPA.
DEHPA |
Aquatic
(mg/l) |
|
|
|
Terrestrial |
Bioaccumulation |
Biodegradation |
|
|
Algae |
Crustaceans |
Fish |
Microorganisms |
|
|
Aerobic |
Anaerobic |
|
|
|
|
|
|
BCF |
28 days |
|
Acute |
50-100 |
42-84 |
20-56 |
443
(IC68, 3h) |
N.D. |
1.1-6 |
0-17%, 75% |
N.D. |
Chronic |
N.D. |
N.D. |
0.3-100
Growth inhibition |
0.3-100
Growth inhibition |
N.D. |
- |
- |
- |
Bioaccumulation
The bioaccumulation of DEHPA is low. A BCF of only up to 6 has been
measured in fish (BUA 1996b). The bioaccumulation potential expressed by LogPow
is also less than three (2.67), and significant bioaccumulation is not
expected.
Aerobic and anaerobic biodegradation
Inconsistent data on the biodegradability of di(2-ethylhexyl) phosphate are
quoted in BUA (1996b). At lower substrate concentration (30 mg/l) the
substance does not biodegrade, but a three times higher concentration the
substance is readily biodegradable. The compound is assessed as inherently
biodegradable
No data on anaerobic degradation is available. There is no data for DEHPA
from sludge, but three phosphate triesters has been found in 11 of 20 sewage
sludge samples at an average of 0.2 to 1.8 mg/kg dryweight (Kristensen et al.,
1996).
Risk assessment
The PNEC is calculated with a safety factor of 1000 since no chronic data
is available. The lowest standard test value is a fish test value of 20 mg/l,
corresponding to a PNEC of 0.02 mg/l.
Table 5.25 Risk Assessment on DEHPA.
Risk assessment |
Aquatic |
|
|
Surfacet |
Sediment |
Estimation |
|
|
Aquatic |
0.019 |
0.01 |
Worst case |
|
|
Aquatic |
0.1 |
0.05 |
Conclusion
The PEC/PNEC ratio does not exceed 1 in any aquatic compartment and hereby
predict no potential effect on organisms in the aquatic water and sediment
compartments.
A terrestrial risk assessment cannot be performed due to lack of toxicity
data.
Physical-chemical properties
Tri(2-ethylhexyl) phosphate (TEHPA) is in general produced and used
similarly to DEHPA.
The solubility data on TEHPA ranges from insoluble in water to <0.5 -
<100 mg/l at 18-24 ºC with one exact solubility
of 0.6 mg/l at 24 ºC. The exact water solubility
on TEHPA indicates that this substance possess a low water solubility.
TEHPA has an estimated vapour pressure of 8.3
10-7 mm Hg at 25 ºC. The magnitude of
the vapour ranges in the lower end of the 11 substances investigated.
The available LogPow values on TEHPA ranges from 0.8-5.0.
Indications of the origin and pH at measurement of the high-end values are
however not available (BUA 1996b). The measured BCF value on TEHPA of 2.4-22
does suggest the LogPow values in the high end of the LogPow
range are overestimates. Similarly to DEHPA, this substance may also be
dissociated at neutral pH. TEHPA is therefore among the substances
investigated that possesses a low lipophilicity. However, as a worst case
assumption a LogPow of 5 has been used in calculating TEHPA in the
sediment compartment.
Migration
No data has been located on the migration potential of TEHPA.
Exposure in the work place
The EASE-calculation focuses on the production of cables.
The following assumptions are made with regard to the workplace exposure:
- production takes place at a temperature of 180 ºC
- required legal exhaust ventilation is in place
- contact with the substance will only take place incidentally, e.g. in
relation to cleaning and maintenance of production equipment.
Possible main exposure routes in the workplace:
Based on this scenario the EASE calculation gives the results shown in
Table 5.26.
Table 5.26 Theoretical values of TEHPA in the working environment according to the
EASE calculation
Route of exposure |
EASE value |
Unit |
Vapour concentration in air for workers |
0.5-3 |
ppm |
Vapour concentration in air for workers |
9.04-54.2 |
mg/m3 |
Potential dermal uptake for workers |
0 |
mg/kg/day |
Consumer exposure
In the EASE calculation focus is on use of cables in a private household.
Possible main routes of consumer exposure:
- inhalation
- dermal contact with consumer goods
- ingestion (children).
Based on this scenario, the EASE calculation gives the results shown in
Table 5.27.
Table 5.27 The theoretical potential daily intake of TEHPA by consumers according to
the EASE calculation
Route of exposure |
Daily intake in mg/kg bw/day |
Ratio of the ADI |
Inhalatory intake |
5.82 x 10-6 |
* |
Dermal uptake |
8.04 x 10-13 |
* |
Oral intake |
0.0286 |
* |
Total chronic uptake via different routes |
0.0286 |
* |
Total acute uptake via different routes |
0 |
* |
*: The ADI has not been established. Other phosphorous acid dialkyl esters
have been allocated a group restriction value of 0.05 mg/kg bw/d based on DEHP
peroxisome proliferation data (SCF, 2000).
Environmental exposure of humans
The amount established in ’Usage’ section is used to calculate exposure
for a number of environmental compartments by EU TGD/EUSES. The dose is mainly
derived from consumption of root crops and meat. This is due to the LogPow
of TEHPA leading to a slight accumulation in agricultural soil. No measured
data are available for accumulation in plants.
Table 5.28 The estimated human doses of TEHPA through intake of water, fish, leaf of
crops, roots of crops, meat, milk and air.
TEHPA |
|
Estimation (~ 2,200 t) |
Worst case (10,700 t) |
|
|
mg/kg/d |
mg/kg/d |
Drinking water |
|
0.00001 |
0.00535 |
Fish |
BCF measured |
0.00002 |
0.00008 |
Plants |
Leaf crops |
0.00002 |
0.00008 |
|
Root crops |
0.0007 |
0.0032 |
Meat |
|
0.00046 |
0.000002 |
Milk |
|
3 10-7 |
1 10-6 |
Air |
|
8 10-8 |
4 10-7 |
Total regional |
|
0.0012 |
0.0087 |
Exposure in the environment
The estimated concentration levels of TEPHA reflect the relatively high
aqueous concentration due to the high solubility with a limited estimated
association with particles (sediment and soils).
Table 5.29 The estimated regional concentrations of TEHPA in water, soil and air.
Compartment |
Aquatic |
|
|
Terrestrial |
|
|
|
Air |
TEHPA |
Surfacet |
Surfaced |
Sediment |
Natural |
Agricultural |
Porewater of agri. soil. |
Industrial |
|
|
mg/l |
mg/l |
mg/kg |
mg/kg |
mg/kg |
mg/l |
mg/kg |
mg/m3 |
Estimation (~ 2,200 t) |
0.0005 |
0.0005 |
0.10 |
0.008 |
0.05 |
0.0004 |
0.2 |
4 10-7 |
Worst case (10,700 t) |
0.0022 |
0.0022 |
0.50 |
0.037 |
0.24 |
0.0019 |
1.2 |
1.7 10-3 |
Secondary poisoning
TEHPA may dissociate in the aqueous environment and the measured and
estimated accumulation potential may therefore not imply risk of secondary
poisoning in the environment.
Table 5.30 The estimated regional concentrations of TEHPA in fish, plants,
meat and milk.
Articles of food |
Wet fish |
Plants |
|
|
Meat |
Milk |
TEHPA |
estimate |
measured |
Roots |
Leaves |
Grass |
|
|
|
mg/kg |
mg/kg |
mg/kg |
mg/kg |
mg/kgww |
mg/kgww |
mg/kgww |
Estimation (~ 2,200 t) |
0.7 |
0.01 |
0.1 |
0.001 |
0.001 |
0.0001 |
0.00003 |
Worst case (10,700 t) |
3.4 |
0.05 |
0.6 |
0.005 |
0.005 |
0.0005 |
0.00016 |
The most significant toxicity data on TEHPA are presented in Table 5.31.
Table 5.31 Selected toxicity data on TEHPA.
Toxicology |
Species |
Protocol |
Dose levels / duration |
Results |
Ref. |
Acute oral toxicity |
Mouse
|
N.D.
|
|
LD50>12,800 mg/kg bw
|
1
|
|
Rat |
N.D. |
|
LD50>2000 mg/kg bw |
4 |
|
Rat |
N.D. |
|
LD50=37,080 mg/kg bw |
4 |
|
Rat |
N.D. |
|
LD50=39,800 mg/kg bw |
4 |
|
Rabbit |
N.D. |
|
LD50=46,000 mg/kg bw |
4 |
Acute inhalation toxicity |
Rat |
N.D. |
450 mg/m3, duration unknown. |
No mortality |
4 |
|
Guinea pig |
N.D. |
450 mg/m3, 0.5 hours |
LC50=450 mg/m3/30 min |
3, 4 |
Acute dermal toxicity |
Rabbit |
N.D. |
N.D. |
LD50=18,400 mg/kg bw |
4 |
Acute toxicity, other routes |
- |
|
|
|
|
Irritation- skin |
Rabbit
|
Applied to shaved skin. |
(24 hours)
|
Moderate erythema within 24 hours. |
4 |
|
Rabbit
|
|
10-20 ml |
Mortality after single application. |
4 |
- eye |
Rabbit
|
N.D.
|
0.1-0.5 ml (24 hours). |
Moderate conjunctivitis which cleared up after 24 hour. |
4
|
|
Rabbit |
N.D. |
0.01-0.05 ml |
Light irritation. |
4 |
Sensitisation |
Guinea pig |
|
|
Not sensitising |
4 |
Repeated dose toxicity |
Mouse (B6C3F1) |
Oral |
0, 500, 1000, 2000, 4000, 8000 mg/kg bw (13 weeks, 5 days /week). |
Dose dependent gastritis, lowest dose 500 mg/kg bw. Decrease in bw
gain. NOEL<500 mg/kg bw. |
4 |
|
Rat (Crj:CD(SD)) |
Oral |
30, 100, 1000 mg/kg bw, (28 days). |
Reduced protrombin time (♀) and increased partial tromboplastin
time (♂). Reduced serumcholineesterase activity.
NOEL= 100 mg/kg bw |
4 |
|
Rat (Sherman)
|
Oral |
110-1550 mg/kg bw/day (30 days) |
Reduced bodyweight gain.
NOEL=430 mg/kg bw/day |
4 |
|
Monkey (Rhesus) |
Inhalation, average particle size=4.4m m. |
10.8, 26.4, 85 mg/m3 (12 weeks, 5 days/weeks, 6 hours/day). |
No effects |
4 |
|
Dog |
Inhalation, average particle size=4.4 m
m. |
10.8, 26.4, 85 mg/m3 (12 weeks, 5 days/weeks, 6
hours/day). |
|
|
|
Rabbit
(New Zealand) |
Dermal |
92 mg/animal/day (5 days/week, 3-17 days) 10-20 appl. |
Hyperkeratose, mild parakeratose, acute dermatitis, thickening of
epidermis. Effects disappeared. |
4 |
Genetic toxicity |
Salmonella typhimurium |
Ames test, +/- |
N.D. |
Not mutagenic. |
4 |
|
CHO cells
|
In vitro mammalian cell gene mutation test, +/- |
Up to 1670m g/ml.
|
No chromosome aberration.
|
4 |
|
Rat |
Micronucleus test |
0, 0.25, 0.50 mg/l air (2 weeks, 5 days / week, 6hrs/day |
No micronuclei |
4 |
Reproductive / developmental toxicity |
- |
|
|
|
|
Carcinogenicity |
Mouse (B6C3F1) |
N.D. (gavage) |
0, 500, 1000 mg/kg 5 days/week (102-104 weeks) |
Increased incidence of hepatocellular carcinoma in female mice at
1000 mg/kg bw. No evidence of carcinogenicity in male mice.. |
1, 2 |
|
Rat |
N.D. (gavage) |
♀: 1000 or 2000 mg/kg bw
♂: 2000 or 4000 mg/kg bw |
♀: No evidence of carcinogenicity
♂: Equivocal evidence of carcinogenicity (increased incidence of
pheochromocytomas in adrenal glands. |
1 |
Experience with human exposure |
Human
|
Irritation test, underarm |
24 hours |
No irritation |
4 |
References: 1) HSDB (2000) 2) CCRIS (2000) 3) NTP (2000) 4) BUA (1996b)
Observations in humans
A 24 hours exposure of the underarm on six test persons did not result in
any irritation of the skin.
Acute toxicity
Tri(2-ethylhexyl) phosphate appears to have very low acute oral toxicity.
LD50 in rats was more than 37.08 g/kg and LD50 was approx. 46.0 g/kg in
rabbits.
Irritation
Tri(2-ethylhexyl) phosphate may produce moderate erythema in skin
irrita-tion test and slight irritation to eyes.
Sensitisation
Sufficient data on skin sensitisation was not found.
Repeated dose toxicity
Repeated dose toxicity observed in rats involved haematological changes
and reduced body weight gain. Slight behavioural changes and minor chronic
infection in lungs were observed in dogs administered 10.8, 26.4, 85 mg/m3
(12 weeks, 5 days/week, 6 hrs/day). No effects were observed in monkeys
receiving the same treatment.
Genetic toxicity
Based on the available data, TEHPA cannot be regarded as mutagenic and has
not been found genotoxic in chromosome aberration test and micronuclei
assays. Neither tri-n-ethyl phosphate nor tri-n-octyl phosphate were found
mutagenic in Salmonella test (Zieger et al., 1987).
Long term toxicity
A slight evidence of carcinogenicity was observed in female mice and
equivocal evidence in male rats (HSDB 2000). Based on the evaluation as
slightly carcinogenic in mice and not mutagenic and genotoxic, it has been
concluded by an ECETOC working group that TEPHA is unlikely to be
car-cinogenic to humans (BUA 1996b). Data on reprotoxicity, embryotoxicity
and teratogenicity were not found.
NOAEL/LOAEL
In repeated dose toxicity tests, the lowest NOEL of 100 mg/kg for TEHPA
was observed in male rats was following 28 days exposure.
Critical effect
Based on the available data the critical effect appears to be
heamatological changes from repeated dose toxicity after oral administration
in rats and local effects on skin and eyes.
Classification
TEHPA has been classified according to the substance directive by Bayer
AG in 1993 as follows: Xi (Irritant); R36/38 (Irritating to skin and
eyes).
Summary of known toxicity
Tri(2-ethylhexyl) phosphate appears to have slight acute oral toxicity.
Slight neurotoxic effects were observed in dogs administered 10.8, 26.4, 85
mg/m3 (12 weeks, 5 days/week, 6 hrs/day). Based on tests in
animals, tri(2-ethylhexyl) phosphate may produce moderate irritation of skin
and eyes, but a 24 hours exposure of the underarm on six test persons did not
result in any irritation of the skin although moderate erythema is observed in
exposed rabbits. Repeated dose toxicity studies in rats have shown
haematological changes at concentrations above the NOEL of 10 mg/kg bw.
Available studies indicate that there slight evidence of carcinogenicity in
female mice and equivocal evidence in male rats. An ECETOC working group ha
concluded that TEHPA is unlikely to be carcinogenic in humans.
Exposure versus toxicity
A comparison between the calculated exposure of consumers and the
available toxicological information about TEHPA indicates that the selected
exposure scenario represents a minor risk to human health, although moderate
erythema is observed in exposed rabbits.
General exposure of the population may occur through dermal contact with
consumer products containing tri(2-ethylhexyl) phosphate and ingestion of
contaminated food. Based on the selected scenario, the EASE-calculation
indicates that the consumer exposure to tri(2-ethylhexyl) phosphate is
relatively small and constitutes a limited contribution to the overall
exposure of humans. Concerning exposure in the working environment exposure
may occur through inhalation of dust particles and dermal contact when working
in places where tri(2-ethylhexyl) phosphate is handled.
The EASE-calculation indicates that the concentration of tri(2-ethylhexyl)
phosphate in the working environment of the selected scenario can reach levels
of up to 55 mg/m3 and 3 ppm. Inhalation of concentrations of this
magnitude has produced high mortality in rats.
Generally, data on environmental effects from TEHP from the acute aquatic
test systems are available. In the following the most sensitive data are
presented.
Table 5.32 Ecotoxicity and fate data on TEHPA.
TEHPA |
Aquatic
(mg/l) |
|
|
|
Terrestrial |
Bioaccumulation |
Biodegradation
(%) |
|
Algae |
Crustaceans |
Fish |
Microorganisms |
|
|
Aerobic |
Anaerobic |
|
|
|
|
|
|
BCF |
28 days |
|
Acute |
50-100
(48 hrs) |
>1.0 |
100
(LC0) |
>100
(3 hrs) |
N.D. |
2-22 |
0 |
25
(1.4 mg/l, 70 days) |
Chronic |
N.D. |
N.D. |
N.D. |
N.D. |
N.D. |
- |
- |
- |
Aquatic and terrestrial ecotoxicity
Based on the available data TEHPA is not toxic to aquatic organisms at
TEHPA water solubility level (up to 0.7 mg/l).
The available acute data on ecotoxicity show that TEHPA is harmful to algae
but the test duration is only 48 hours and not 72 hours as prescribed in the
recommended method, it is not possible to classify the toxicity more
precisely. A test on the ciliate Tetrahymena pyriformis is also
available where the LC50was 10 mg/l (Yoshioka et al., 1985).
TEHPA is not toxic to fish. In an acute 96 hours fish test with Brachydanio
rerio LC0 was more than 100 mg TEHPA/l (Bayer 1999).
No chronic data was available.
Bioaccumulation
The available measured BCF values indicate that TEHPA is not
bioaccumulative Chemicals Inspection and Testing Institute, 1992). Log Pow
values range from 0.8 to 5.04 predicting that TEHPA range from not
bioaccumulative to bioaccumulative.
Aerobic and anaerobic biodegradation
TEHPA is not readily biodegradable according to the available aerobic ready
biodegradation data (Chemicals Inspection and Testing Institute, 1992). The
compound is slowly biodegraded under anaerobic conditions when present in weak
solutions.
There is no data for TEHPA itself in Denmark, but three other phosphate
triesters were found in 11 of 20 sewage sludge samples at an average of 0.2 to
1.8 mg/kg dryweight (Kristensen et al., 1996) suggesting incomplete
degradation in sewage treatment plants.
Risk assessment
The PNEC is calculated with a safety factor of 1000 since data is
available for algae, crustacean and fish, and no chronic data is available
(Pedersen et al., 1995).
The lowest aquatic EC/LC50 is 50, corresponding to an aquatic
PNEC of 0.05. In the following Table 5.33 the result of the risk assessment is
presented.
Table 5.33 Risk Assessment on TEHPA
Risk assessment |
Aquatic |
|
|
Surfacet |
Sediment |
Best guess |
|
|
Aquatic |
0.01 |
0.001 |
Worst case |
|
|
Aquatic |
0.05 |
0.005 |
According to the risk assessment the PEC will not exceed the PNEC in the
aquatic compartment.
No ecotoxocity data were available on organisms living in the neither in
the sediment or in soil.
The family of trimellitates, pyromellitates and other polycarboxylic
acid esters are used for heat resistant plasticised PVC articles due to
their excep-tional thermal properties. Trimellitates are similar to
phthalates in compatibility and plasticising effect.
Physical-chemical properties
This group is esters of trimellitic acid (1,2,4-benzene tricarboxylic
acid) and generally have a higher molecular weight and corresponding lower
vapour pressure resulting in a lower migration potential to aqueous solutions
compared to phthalates and other plasticisers.
The available solubility data of Tri-2-ethylhexyl trimellitate (TETM)
ranges from <100-100 mg/l at 20-25 C. The
upper end of the water solubility range places TETM among the relatively
soluble substances investigated.
TETM has an estimated vapour pressure of 3.94 10-11
mm Hg at 25 C, which is a very low vapour
pressure when compared to the other nine substances.
The only measured LogPow value of 4.35 (European Commission
Joint Research Centre, 1996), indicates that TETM is lipophilic. The structure
of this substance also supports high (above 3) LogPow values. TETM
is among the more lipophilic substances in this assessment.
Migration
In a study of plasticisers in polypropylene packaging for foods TETM was
accidentally found almost half the samples (in the printing ink), but
migration was not studied (Nerín et al., 1993).
Migration from PVC to sunflower oil, isooctane or ethanol was 1,280; 1,220
and 450 mg/dm2 respectively in studies over 1-3 days at the same
temperature (Hamdani, Feigenbaum 1996), corresponding to 30-80% of the total
TETM amount in the PVC piece. This was approx. twice the migration observed of
DEHP. The two PVC samples contained 23.5% DEHP and 27.5% TETM, respectively.
Blood platelet bags, which contained tri-(2-ethylhexyl) trimellitate as a
plasticiser, showed that a negligible amount of it leached into calf serum
(Chawla et al., 1991).
Use pattern for compound
The main uses of TETM may be in PVC-products used e.g. in the hospital
sector, packing, cables, profiles and floor and wall coverings, cf. Table 4.6.
Exposure in work the place
Focus in the EASE-calculation is on the production of cables.
The following assumptions are made with regard to the workplace exposure:
- production takes place at a temperature of 180 °C
- required legal exhaust ventilation is in place
- contact with the substance will only take place incidentally, e.g. in
relation to cleaning and maintenance of production equipment.
- Possible main exposure routes in the workplace:
- inhalation of vapours.
Based on this scenario, the EASE calculation provides the results shown in
Table 5.34.
Table 5.34 Estimated values of TETM in the working environment
according to the EASE calculation
Route of exposure |
EASE value |
Unit |
Vapour concentration in air for workers |
3-10 |
ppm |
Vapour concentration in air for workers |
68.2-227 |
mg/m3 |
Potential dermal uptake for workers |
0 |
mg/kg/day |
Consumer exposure
The EASE calculation focus has on use of cables in a normal private
house.
Based on this scenario the EASE calculation gives the results shown in
Table 5.35.
Table 5.35 The estimated potential daily intake of TETM by consumer
according to the EASE calculation
Route of exposure |
Daily intake in mg/kg bw/day |
Ratio of the ADI |
Inhalatory intake |
2.16 x 10-16 |
* |
Dermal uptake |
8.04 x 10-21 |
* |
Oral intake |
0 |
* |
Total chronic uptake via different routes |
1.62 x 10-16 |
* |
Total acute uptake via different routes |
0 |
* |
*: The ADI has not been established. A Group restriction value of 0.05
mg/kg bw/d based on DEHP peroxisome proliferation data has conservatively been
assigned to other dialkyl esters.
Environmental exposure of humans
The amount established in the ’Usage’ section is used to calculate
exposure for a number of environmental compartments by EU TGD/EUSES. A
restriction value of 0.05 mg/kg bw/d (Group R) for food contact materials have
been allocated (SCF, 2000) for TETM, and this value is not exceeded according
to the EUSES estimates. Furthermore, as an ester TETM may potentially
hydrolyse in the gastro-intestinal fluid. Whether this also may occur to some
extent in the environment is not clear, and no data is available for TETM on
this property.
Table 5.36 The estimated human doses of TETM through intake of
water, fish, leaf of crops, roots of crops, meat, milk and air.
TETM |
|
Estimation (~ 1,800 t) |
Worst case (10,700 t) |
|
|
mg/kg/d |
mg/kg/d |
Drinking water |
|
4.6 10-8 |
2.6 10-7 |
Fish |
BCF estimated* |
1.0 10-5 |
6.0 10-5 |
Plants |
|
|
|
|
Leaf crops |
1. 10-11 |
8 10-11 |
|
Root crops |
4 10-10 |
2 10-9 |
Meat |
|
6 10-10 |
4 10-9 |
Milk |
|
4 10-10 |
2 10-9 |
Air |
|
3 10-7 |
2 10-6 |
Total regional |
|
1.0 10-5 |
6.2 10-5 |
* Measured BCF value not available
Exposure in the environment
The estimated concentration levels of TETM reflects the low solubility in
aqueous solutions combined with the extraordinary high estimated LogPow
and a resulting association with particles (sediment and soils).
Table 5.37 The estimated regional concentrations of TETM in water,
soil and air.
Compartment |
Aquatic |
|
|
Terrestrial |
|
|
|
Air |
TETM |
Surfacet |
Surfaced |
Sediment |
Natural |
Agricultural |
Porewater of agri. Soil. |
Industrial |
|
|
mg/l |
mg/l |
mg/kg |
mg/kg |
mg/kg |
mg/l |
mg/kg |
mg/m3 |
Estimation (~ 1,800 t) |
6 10-6 |
6 10-6 |
0.00092 |
2 10-10 |
9 10-8 |
4 10-10 |
8 10-7 |
1 10-6 |
Worst case (10,700 t) |
4 10-5 |
4 10-5 |
0.0054 |
1 10-9 |
5 10-7 |
2 10-9 |
5 10-6 |
8 10-6 |
Secondary poisoning
ETM has an extraordinary high estimated LogPow, which may give
rise to high bioaccumulation provided BCF also increases, and consequently a
risk of secondary poisoning.
TETM has a potential for secondary poisoning if the evaluation is based on
the estimated BCF alone and the estimated LogPow. However, if TETM
occurs under acidic or basic conditions a hydrolysis may take place thus
cleaving the ester bond producing the trimellitic acid and 2-ethylhexanols.
Whether this also may occur to some extent in the environment is not clear,
and no data is available for TETM. Trimellitic anhydride formed from the acid
at elevated temperature has a range of respiratory effects.
Table 5.38 The estimated regional concentrations of TETM in fish,
plants, meat and milk.
Articles of food |
Wet fish |
Plants |
|
|
Meat |
Milk |
TETM |
Estimate |
measured |
Roots |
Leaves |
Grass |
|
|
|
mg/kg |
mg/kg |
mg/kg |
mg/kg |
mg/kgww |
mg/kgww |
mg/kgww |
Estimation (~ 1,800 t) |
0.0063 |
n/a |
8 10-8 |
8 10-10 |
0.0001 |
1 10-7 |
5 10-8 |
Worst case (10,700 t) |
0.037 |
n/a |
4 10-7 |
5 10-9 |
0.0008 |
9 10-7 |
3 10-7 |
Key toxicity data on TETM are presented Table 5.39.
Table 5.39 Selected toxicity data on TETM.
Toxicology |
Species |
Protocol |
Dose levels / duration |
Results |
Ref. (datasheet) |
Acute oral toxicity |
Mouse
Rat
Rat |
N.D.
N.D.
N.D. |
|
LD50>3.2 g/kg bw
LD50>3.2 g/kg bw
LD50=9.85 g/kg bw |
2, 3
1, 3
2 |
Acute inhalation toxicity |
Rat |
N.D. |
4 hrs |
LC50=2.6 mg/l |
2, 3 |
Acute dermal toxicity |
Rabbit |
OECD 402/1981 |
24 hrs, covered |
LD50=1.97 g/kg bw. No overt clinical signs |
2 |
Acute toxicity, other routes |
Rat |
i.p. |
|
LD50=3,200 mg/l |
2 |
Irritation
- skin |
Rabbit
|
OECD 404/1984 |
0.5 ml, occlusive, 24 hrs |
Slightly irritating |
2 |
- eye |
Rabbit |
OECD 405/1984 |
0.1 ml |
Slightly irritating |
2 |
- inhalation |
Rat |
N.D. |
230 mg/m3, 6 hrs |
Minimal irritation, no deaths |
2 |
|
Rat |
N.D. |
16 ppm, 6 hrs |
Moderate irritation |
2 |
|
Rat |
N.D. |
2640 mg/m3, 6 hrs |
Severe irritation |
3 |
Sensitisation |
Guinea pig |
OECD 406/1981 |
0.5 ml, occlusive, 24 hrs, 10 applications |
Not sensitising |
2, 3 |
Repeated dose toxicity |
Rat (Fisher 344)
|
Oral
|
0, 184, 650, 1826 mg/kg bw in diet (28 days). |
LOAEL=184 mg/kg bw/day, slightly increased liver weights, slight
peroxisome proliferation |
2
|
|
Dog |
N.D. |
14 and 42 mg/kg bw/day
injections for 14 days |
Increased relative liver and spleen weight in top dose group.
LOAEL=42 mg/kg bw/day |
2 |
Genetic toxicity |
Salmonella typhimurium |
Ames test, +/-
|
N.D.
|
Not mutagenic
|
2
|
|
CHO cells |
In vitro mammalian cell gene mutation test, +/- |
5-200 nl/ml |
No chromosome aberration |
2 |
|
Rat hepatocytes |
HGPRT assay +/- |
250-5000 nl/ml |
No indication of UDS |
2 |
Reproductive / developmental toxicity |
- |
|
|
|
|
Carcinogeni-city |
Mouse (A) |
N.D. |
1,400 mg/kg bw/day |
Negative |
2 |
Experience with human exposure |
Human
|
Inhalation |
Mist and fumes from hot processing |
May irritate eyes, nose, throat and upper respiratory tract |
1 |
References: 1) European Commission Joint Research Centre (1996), 2)
European Commission Joint Research Centre (2000), 3) TNO BIBRA International
Ltd (1993)
Observations in human
Mist and fumes from hot processing may cause irritation, nausea and
vomiting.
Acute toxicity
TETM has been found to be of low acute oral and dermal toxicity in
laboratory animals. By inhalation the substance is more toxic and should be
classified as Xn (Harmful); R20 (Harmful by inhalation)
according to the classification criteria.
Irritation
TETM has been shown to irritate the skin of guinea pigs, rabbits and mice
and the eyes of rabbits (European Commission Joint Research Centre, 2000).
TETM has been shown to cause irritation when it is inhaled in rat studies
(TNO BIBRA, 1993).
Sensitisation
An attempt to induce sensitisation in 10 guinea-pigs did not show any sign
of effect (TNO BIBRA, 1993).
Repeated dose toxicity
Increased weight of liver and spleen were reported in dogs following i.p.
exposure for 14 days. LOAEL was 42 mg/kg bw/day (European Commission Joint
Research Centre, 2000), In rats 28 days administration of TETM in the diet
resulted in slightly increased liver weights and peroxisome proliferation.
LOAEL was 184 mg/kg bw/day (European Commission Joint Re-search Centre,
2000).
Genetic toxicity
TETM is not found to produce any genotoxic effects, and the available data
do not indicate that TETM is mutagenic (European Commission Joint Research
Centre, 2000).
Long term toxicity
Signs of reproductive toxicity or carcinogenicity were not reported in the
available data from laboratory studies. TETM was found to be negative in a
cancer study with mouse (European Commission Joint Research Centre, 2000).
NOAEL/LOAEL
The lowest identified LOAEL was 42 mg/kg bw/day following injections in
dogs for 14 days and 184 mg/kg bw/day following oral exposure in rats
(European Commission Joint Research Centre, 2000).
Summary of known toxicity
TETM has been found to be of low acute oral and dermal toxicity in
laboratory animals.
The skin of guinea pigs, rabbits and mice can be irritated by TETM, which
is also seen to irritate eyes of rabbits. TETM can cause irritation when
inhaled by rats.
Repeated oral administration of TETM in rats produced slightly increased
liver weights and peroxisome proliferation. Repeated injections in dogs
resulted in increased liver and spleen weights.
Critical effect
The identified critical effects related to lung changes observed in rats
from inhalation of the substance.
Classification
Based on one available inhalation study TETM should be classified Xn (Harmful);
R20 (Dangerous by inhalation). Other effects cannot be evaluated
properly.
Exposure versus toxicity
A comparison between the calculated exposure of consumers and the
available toxicological information about TETM indicates that the selected
exposure scenario represents a limited risk to human health. Slight irritation
may be expected.
General exposure of the population may occur through dermal contact with
consumer products containing TETM and ingestion of contaminated food. Based on
the selected scenario, the EASE-calculation indicates that the exposure of
TETM in consumers represents very small values and therefore probably
constitutes a limited contribution to the overall exposure of consumers.
Concerning exposure in the working environment, exposure may occur through
inhalation of dust particles and dermal contact when working at places where
TETM is handled. The EASE-calculation indicates that the concentration of TETM
in the working environment in relation to the selected scenario can reach
levels of up to 227 mg/m3 and 10 ppm. Rats exposed to 10 times this
concentration level have shown minimal irritation, but precautionary measures
may be necessary.
Generally, data on environmental effects from TETM are not available. Only
data on biodegradation are available. In the following the most sensitive data
are presented.
Table 5.40 Ecotoxicity and fate data on TETM.
TETM |
Aquatic
(mg/l) |
|
|
|
Terrestrial |
Bioaccumulation |
Biodegradation
(%) |
|
Algae |
Crustaceans |
Fish |
Microorganisms |
|
|
Aerobic |
Anaerobic |
|
|
|
|
|
|
BCF |
28 days |
|
Acute |
N.D. |
>1
|
>1
|
N.D. |
N.D. |
N.D. |
14, OECD 301C |
N.D. |
Chronic |
N.D. |
0.082
NOEC 21d |
N.D. |
N.D. |
N.D. |
- |
- |
- |
N.D.: No data available.
Aquatic and terrestrial ecotoxicity
Very limited data on aquatic ecotoxicity of TETM are available (European
Commission Joint Research Centre, 2000), but in these experiments TETM is not
acutely toxic at solubility limit. A NOEC from a 21 days chronic experiment is
available. No data on terrestrial ecotoxicity were identified.
Bioaccumulation
No BCF data were available, but LogPow is above three (4.35),
and bioaccumulative properties may therefore be expected. The molecular weight
is close to 600, which may be assumed to limit the membrane transport and
general uptake of the compound.
Aerobic and anaerobic biodegradation
The available data indicates that TETM does not biodegrade readily
(European Commission Joint Research Centre, 2000). It should be noted that the
conditions of the biodegradation test were not listed in the reference, and it
cannot be determined whether the degradation is in reality ready or inherent.
Risk assessment
The data availability is insufficient for calculating PNECs according to
the EU TGD, since only two acute tests are available. If, however, it is
assumed that a PNEC for water based on e.g. the NOEC/100 is acceptable, the
assessment gives the following results (PNEC for water 0.0008 mg/l):
Table 5.41 Risk Assessment on TETM (based on incomplete data set)
Risk assessment |
Aquatic |
|
|
Surfacet |
Sediment |
Best guess |
|
|
Aquatic |
0.0075 |
0.005 |
Worst case |
|
|
Aquatic |
0.05 |
0.026 |
Based on the experience with phthalates and the relatively high
octanol-water partition coefficient of TETM, it may be assumed that the potential
for environmental effects is associated with the accumulation of the compound
in biota, in aquatic sediments and in soils amended with sewage sludge.
Physical chemical properties
Alkyl sulfone esters are based on phenol, sulphate, and an alkyl chain.
The sulfone esters are more resistant toward hydrolysis than other ester based
plasticisers.
The available solubility data of o-toluene sulfonamide (OTSA) ranges from
slightly soluble in water to 1.62 g/l at 25 C.
OTSA is relatively soluble compared to the other investigated compounds.
OTSA has an estimated vapour pressure 6 10-5
at 25 C, which is one of the highest vapour
pressure among the compounds investigated.
Only one measured value LogPow of 0.84 is available on OTSA
(HSDB 2000). The Pow value places OTSA among the least lipophilic
compounds investigated here.
Migration
Less than 0.2 mg/kg (detection limit) migrated from package material
containing 0.96-3.3 mg/dm2 to food (Nerín et al., 1993). The OTSA
concentration in the packaging material was, however, 100 times lower than for
other plasticisers.
Use pattern for compound
OTSA is not used much presently for plasticising purposes, and
information has proven difficult to obtain. In the substitution process it is
assumed that the main uses of OTSA may be in PVC-cables, cf. Table 4.6.
Exposure in the work place
The EASE-calculation focuses on the production of cables.
The following assumptions are made with regard to the workplace exposure:
- production takes place at a temperature of 180 °C
- required legal exhaust ventilation is in place
- contact with the substance will only take place incidentally, e.g. in
relation to cleaning and maintenance of production equipment.
Based on this scenario the EASE calculation provides the results shown in
Table 5.42.
Table 5.42 Estimated values of OTSA in the working environment
according to the EASE calculation.
Route of exposure |
EASE value |
Unit |
Vapour concentration in air for workers |
0.5-3 |
ppm |
Vapour concentration in air for workers |
3.56-21.4 |
mg/m3 |
Potential dermal uptake for workers |
0 |
mg/kg/day |
Consumer exposure
In the EASE, focus is on the use of cables in a private household.
Based on this scenario the EASE calculation provides the results shown in
Table 5.43.
Table 5.43 The estimated potential daily intake of OTSA by
consumers according to the EASE calculation.
Route of exposure |
Daily intake in mg/kg bw/day |
Ratio of the ADI |
Inhalatory intake |
5.82 x 10-6 |
* |
Dermal uptake |
8.04 x 10-13 |
* |
Oral intake |
0 |
* |
Total chronic uptake via different routes |
4.36 x 10-6 |
* |
Total acute uptake via different routes |
0 |
* |
*: The ADI has not been established
Environmental exposure of humans
The EUSES-calculation indicates that humans may by exposed for the
substance as illustrated in the following table.
Table 5.44 The estimated human doses of OTSA through intake of
water, fish, leaf of crops, roots of crops, meat, milk and air.
OTSA |
|
Estimation (30 t) |
Worst case (10,700 t) |
|
|
mg/kg/d |
mg/kg/d |
Drinking water |
|
0.000002 |
0.000253 |
Fish |
BCF estimated* |
2 10-7 |
2.1 10-5 |
Plants |
Leaf crops |
1 10-7 |
5.2 10-5 |
|
Root crops |
2 10-8 |
5.2 10-6 |
Meat |
|
2 10-11 |
2.4 10-9 |
Milk |
|
3 10-10 |
4 10-8 |
Air |
|
1 10-10 |
5 10-8 |
Total regional |
|
0.000002 |
0.000331 |
* Measured BCF value not available
Exposure in the environment
The estimated concentration levels of OTSA show that concentrations in
the aqueous compartment are relatively high compared to other plasticisers due
to the high solubility of OTSA.
Table 5.45 The estimated regional concentrations of OTSA in water,
soil and air.
Compartment |
Aquatic |
|
|
Terrestrial |
|
|
|
Air |
OTSA |
Surfacet |
Surfaced |
Sediment |
Natural |
Agricultural |
Porewater of agri. soil |
Industrial |
|
|
mg/l |
mg/l |
mg/kg |
mg/kg |
mg/kg |
mg/l |
mg/kg |
mg/m3 |
Estimation (30 t) |
0.0001 |
0.0001 |
0.00005 |
9 10-7 |
9 10-7 |
3 10-6 |
1 10-5 |
7 10-10 |
Worst case (10,700 t) |
0.0089 |
0.0089 |
0.00634 |
3.1 10-4 |
3.1 10-4 |
9.4 10-4 |
3.4 10-3 |
2.4 10-7 |
Secondary poisoning
Due to the high aqueous solubility and low LogPow the is no
indication of risk of secondary poisoning from OTSA.
Table 5.46 The estimated regional concentrations of OTSA in fish,
plants, meat and milk.
Articles of food |
Wet fish |
Plants |
|
|
Meat |
Milk |
OTSA |
estimate |
measured |
Roots |
Leaves |
Grass |
|
|
|
mg/kg |
mg/kg |
mg/kg |
mg/kg |
mg/kgww |
mg/kgww |
mg/kgww |
Estimation (30 t) |
0.0001 |
N/A |
3 10-6 |
9 10-6 |
9 10-6 |
4 10-9 |
4 10-8 |
Worst case (10,700 t) |
0.0125 |
N/A |
9.6 10-4 |
3.0 10-3 |
3.0 10-3 |
6 10-7 |
6 10-6 |
The key toxicity data on OTSA are presented in Table 5.47.
Table 5.47 Selected toxicity data on OTSA. No data on acute
toxicity, irritation, sensitivity or subchronic toxicity were identified.
Toxicology |
Species |
Protocol |
Dose levels / duration |
Results |
Ref. |
Acute oral toxicity |
- |
|
|
|
|
Acute inhalation toxicity |
- |
|
|
|
|
Acute dermal toxicity |
- |
|
|
|
|
Acute toxicity, other routes |
- |
|
|
|
|
Irritation
- skin |
- |
|
|
|
|
- eye |
- |
|
|
|
|
Sensitisation |
- |
|
|
|
|
Repeated dose toxicity |
- |
|
|
|
|
Genetic toxicity |
Salmonella typhimurium |
Ames test |
N.D |
Not mutagenic |
2 |
|
Salmonella sp. |
Modified Salmonella/microsome test |
N.D. |
Weak mutagenic effect. |
1 |
Reproductive / developmental toxicity |
Rat |
N.D. (gavage) |
0-250 mg/kg throughout gestation and lactation |
Dose-response for bladder calculi in 21-day-old pubs and 105-day old
rats. Found to be teratogenic. |
1 |
Carcinogenicity |
Rat
|
N.D. (oral)
|
N.D.
|
Limited evidence.
|
1
|
|
Rat |
N.D. (oral) |
0, 20 and 200 mg/kg bw.
(lifetime) |
No increased incidence of malignant tumours. |
1 |
Experience with human exposure* |
A 2-month old infant
|
Oral dose
|
1,500 mg dose of sulfasalazine (same group as o-toluene-sulphonamide) |
No symptoms of toxicity following inadvertent uptake. |
1 |
* Only information on chemically related products; References: 1) HSDB
(2000), 2) Genetox (2000)
Observations in humans
No information regarding OTSA is available. A 2-month old infant did not
develop symptoms of toxicity following inadvertent uptake of a 1,500 mg dose
of sulfasalazine (same group as o-toluene sulphonamide).
One patient developed seizures, coma, hypoxia, hyperglycemia, metabolic
acidosis and methemoglobinemia after an oral dose of 50 mg sulfasalazine and
50 mg paracetamol.
Overdose of sulfasalazine resulted in coma in one patient and tremor in
another.
Acute toxicity
Relevant data not found.
Irritation
Relevant data not found.
Sensitisation
Relevant data not found.
Repeated dose toxity
Relevant data not found.
Generic toxicity toxicity
OTSA is reported to exhibit only weak mutagenic activity (Genetox
2000).
Long term toxicity
OTSA has been reported to be teratogenic in rats (HSDB 2000). This,
however, is based on studies without detailed descriptions of the study
design.
In connection with assessment of saccharine and its impurities, among
others OTSA, it has been found that these impurities are responsible for
the reproductive effects of impure saccharine.
There is limited evidence that OTSA is carcinogenic when administered
orally to rats. This has been suggested as the cause of carcinogenicity of
saccharin. The available data suggest that OTSA impurities at the levels
normally found in commercial saccharin do not contribute to the
carcinogenicity of saccharin
NOAEL/LOAEL
No NOAEL or LOAEL has been established.
Summary of known toxicity
O-toluene sulphonamide has been reported to be teratogenic in rats, but
only exhibiting a weak mutagenic activity.
There is limited evidence that o-toluene sulphonamide is carcinogenic when
administered orally to rats.
Critical effect
Based on very limited data the critical effect has been identified as
possible teratogenicity observed in rats.
Classification
It is not possible to evaluate the data against the classification
criteria for teratogenicity, as information is too sparse. Other described
effects are not classifiable.
E xposure versus toxicity
A comparison between the calculated exposure of consumers and the
available toxicological information about OTSA indicates that the selected
exposure scenario represents a minor risk to human health.
General exposure of the population may occur through dermal contact with
consumer products containing OTSA and ingestion of contaminated food. Based on
the selected scenario, the EASE-calculation indicates that the exposure of
OTSA in consumers represents very small values and therefore probably
constitutes a limited contribution to the overall exposure of consumers.
Concerning exposure in the working environment, exposure may occur through
inhalation of dust particles and dermal contact when working in places where
OTSA is handled. The EASE-calculation indicates that the concentration of OTSA
in the working environment of the selected scenario can reach levels of up to
21.4 mg/m3 and 3 ppm. Data are not available for comparison.
Generally, data on environmental effects from OTSA are not available. Only
data on bioaccumulation and biodegradation are available. In the following the
most sensitive data are presented.
Table 5.48 Ecotoxicity and fate data on OTSA
OTSA |
Aquatic
(mg/l) |
|
|
|
Terrestrial |
Bioaccumulation |
Biodegradation
(%) |
|
Algae |
Crustaceans |
Fish |
Microorganisms |
|
|
Aerobic |
Anaerobic |
|
|
|
|
|
|
BCF |
28 days |
|
Acute |
N.D. |
N.D. |
N.D. |
N.D. |
N.D. |
0.4-2.6 |
0
(14 days) |
N.D. |
Chronic |
N.D. |
N.D. |
N.D. |
N.D. |
N.D. |
- |
- |
- |
N.D.: No data available.
Aquatic and terrestrial ecotoxicity
No data on aquatic organisms or on terrestrial ecotoxicity of OTSA were
available.
Bioaccumulation
The available measured BCF indicate that OTSA do not bioaccumulate (Chemicals
Inspection and Testing Institute, 1992). The compound has no potential for
bioaccumulation based on the measured LogPow (0.84).
Aerobic and anaerobic biodegradation
According to the available data OTSA do not biodegradable readily or inherently
(Chemicals Inspection and Testing Institute, 1992).
Risk assessment
The data available are insufficient for calculating PNECs or providing other
indications of ecotoxicity for the assessment of risk of OTSA.
Based on the physical-chemical properties of OTSA, it must be assumed that
the potential for environmental effects is associated with the relatively high
aqueous solubility and consequent distribution to the aquatic environment.
Physical chemical properties
Very little or no data is available on production and properties of
2,2,4-trimethyl 1,3-pentandiol diisobutyrate (TXIB).
The solubility data of 1,3-pentandiol diisobutyrate measured at an unknown
temperature is 0.001-0.002 g/l. TXIB is relatively insoluble compared to the
other investigated compounds.
In the latest edition of IUCLID (2000) an estimated vapour pressure of TXIB
is given (0.009), but no unit is reported. An EUSES assessment can not be
performed due to an incomplete data set.
Only an estimated value LogPow of 4.1 based on
extrapolation after liquid chromatography is available for TXIB (European
Commission Joint Research Center, 2000). The Pow value places TXIB
among the more lipophilic compounds investigated here.
Use pattern for compound
The main uses of TXIB may be in the PVC-products used e.g. in the hospital
sector, packing, cables, profiles, floor and wall coverings, printing ink and
paint/lacquer, cf. Table 4.6.
Exposure in the work place
Sufficient physical-chemical data have not been available to perform an EASE
calculation.
It is estimated that part of the production is a calendar/press. This process
has been assumed to take place at a temperature of 200 º C and with the legally
required exhaust ventilation. It is further assumed that contact with the
substance may be extensive due to formation of aerosols during the production.
Based on this scenario, and in recognition of the lack of data concerning
health, it may be concluded that TXIB may occur in the working environment in
concentrations, which can be of concern. However, there is a need for more
information to substantiate this conclusion.
Consumer exposure
The lack of available physical-chemical and toxicological data points at a need
for further investigation of the exposure of the substance to consumers.
Exposure in the environment
Insufficient data is available for estimation of environmental concentrations
with the EUSES model.
Summary of known toxicity
The key available toxicity data for TXIB are presented in Table 5.49.
Table 5.49 Selected toxicity data on TXIB.
Toxicology |
Species |
Protocol |
Dose levels / duration |
Results |
Ref. |
Acute oral toxicity |
Rat |
N.D. |
|
LD50 > 3,200 mg/kg bw |
1 |
Acute inhalation toxicity |
Rat |
N.D. |
0.53 or 0.12 mg/l for 6h |
LC50 > 5.3 mg/l |
1 |
Acute dermal toxicity |
Guinea pig |
N.D. |
|
LD50 > 20 ml/kg |
1 |
Acute toxicity, other routes |
Rat |
N.D. (i.p.) |
|
LD50 approx. 3,200 mg/kg bw |
1 |
Irritation
- skin |
Guinea pig |
N.D. |
Covered and uncovered. Dose not mentioned. |
Slight skin irritation when uncovered. More irritating when covered. |
1 |
- eye |
Rabbit |
OECD 405 |
0.1 ml |
Not irritating |
1 |
Sensitisation |
Guinea pig |
OECD 406 |
Injection via foot pad. No detailed information |
Not sensitising |
1 |
Repeated dose toxicity |
Sprague Dawley rats |
N.D. (oral) |
0.1 and 1 % w/w for 52 or 99 days |
NOAEL = 0.1%
LOAEL=1%
Reversible liver weight change in high dose group |
1 |
|
Dog (Beagle) |
N.D. (oral) |
0.1%, 0.35%, 1%
13 weeks |
No significant findings |
1 |
Genetic toxicity |
- |
|
|
|
|
Reproductive / developmental toxicity |
- |
|
|
|
|
Carcinogenicity |
- |
|
|
|
|
Experience with human exposure |
- |
|
|
|
|
References 1) European Commission Joint Research Centre (2000)
Acute toxicity
Acute toxicity has been tested at doses where no effects were observed. Precise
LD50-values are therefore not identified ((European Commission Joint
Research Centre, 2000).
Irritation
TXIB was observed to be slightly irritating in guinea pigs, especially when
covered, but has not been observed to be irritating to rabbit eyes (European
Commission Joint Research Centre, 2000).
Sensitisation
Sensitisation has not been observed in the reviewed data (European Commission
Joint Research Centre, 2000).
Repeated dose toxicity
In a repeated dose toxicity study in rats reversible liver weight changes
were observed in the high dose group (1%) (European Commission Joint Research
Centre, 2000).
Genetic toxicity
No data available.
Long term toxicity
No data available.
NOAEL/LOAEL
In a repeated dose toxicity study in rats a NOAEL of 0.1% TXIB in the diet. has
been identified. Reversible liver weight changes were observed in the high dose
group (1%) (European Commission Joint Research Centre, 2000).
Critical effect
The critical effect based on the available data appears to be the repeated dose
toxicity following oral administration in rats.
Classification
It id not possible to conclude about the classification of TXIB based on the
available literature.
Summary of known toxicity
The few available data indicate that TXIB is a substance of low toxicity.
Results from animal tests do not fulfil the classification criteria with regard
to acute toxicity, skin and eye irritation and skin sensitisation. Reversible
liver changes were found rats in a chronic study whereas chronic toxicity
testing in beagles did not reveal any significant findings.
The only available data on TXIB is the estimated LogPow of 4.1,
which indicates that this compound is lipophilic with some potential for
bioaccumulation (LogPow >3).
Only a very limited data set is available on aquatic ecotoxicity for TXIB. No
effects were apparently observed in the reported test ranges, and a NOEC
(96h) for these acute tests are given as 1.55 mg/l. No information on
terrestrial ecotoxicity of TXIB was available.
Aerobic and anaerobic biodegradation cannot be evaluated since no data or
incomplete data on TXIB were available.
Table 5.50 Ecotoxicity and fate data on TXIB.
TXIB |
Aquatic
(mg/l) |
|
|
|
Terrestrial |
Bioaccumulation |
Biodegradation
(%) |
|
Algae |
Crustaceans |
Fish |
Microorganisms |
|
|
Aerobic |
Anaerobic |
|
|
|
|
|
|
BCF |
28 days |
|
Acute |
N.D. |
>1.46
LC50 (96h) |
>1.55
|
N.D. |
N.D. |
N.D. |
99.9 % at
650 mg/l (incomplete) |
N.D. |
Chronic |
N.D. |
N.D. |
N.D. |
N.D. |
N.D. |
N.D. |
N.D. |
N.D. |
N.D.: No data available.
Risk assessment
The data availability is insufficient for calculating PNECs or providing
other indications of ecotoxicity for the assessment of risk of TXIB.
Physical-chemical properties
Epoxidised soybean oil (ESBO) the dominant plasticiser among the
epoxidised oils and is produced by epoxidation of soybean oil. ESBO has a
high molecular weight and a spacious molecular structure. These two
properties in combination make ESBO more resistant to migration. The high
molecular weight and the linear structure of ESBO cause these plasticisers
to work less effective at lower temperatures.
The only available data on ESBO is the estimated LogPow of
>6 which indicates that this compound is lipophilic (Syracuse Research
Corporation, 2000). When compared to the other investigated substances,
the magnitude of the LogPow value is in the higher end.
Migration
ESBO (used as a stabiliser) showed limited migration from PVC to three
lipophilic solvents in the study by Hamdani and Feigenbaum (1996).
Typically, approx. half the migration observed for DEHP and less than half
compared to TETM. However, in the more polar ethanol ESBO migrate equal to
or more than the other plasticisers.
Gilbert et al. (1986) demonstrated that ESBO migrated from PVC bottles
to diethyl ether in a 10 days test at 306 mg/dm2 or 3,492
mg/kg. The ESBO was characterised as ranging from C12 to C20
with mainly epoxy-oleate (25%) and epoxy-linoleate (52%). Migration of
ESBO into three aqueous simulants (water, 50% ethanol and 3% acetic acid)
ranged from 0.23 to 0.3 mg/kg.
Levels of ESBO in fresh retail meat samples wrapped in film ranged from
less than 1 to 4 mg/kg, but were higher in cooked food and in foods heated
in microwave oven (Castle et al., 1990).
The available data on physical-chemical properties does not suffice to
establish an EUSES scenario. This is a general problem for mixtures.
Use pattern for compound
The main uses of ESBO may be in PVC-products such as those used in
packing, cables, printing ink, paint/lacquer, adhesives and fillers, cf.
Table 4.6.
Exposure in the work place
Since ESBO is a mixture of different substances, it is not possible to
make an EASE-calculation. As seen in the next section, ESBO may be
regarded as only slightly acute toxic by ingestion.
As a worst-case situation involving ESBO in the working environment,
professional painting in a room with out ventilation (e.g. a private
household) has been selected.
It is concluded that the exposure in the work place is of minor
importance, since the substance is mainly toxic by ingestion. Normal
hygiene in the working environment, such as washing hands before eating,
is sufficient to reduce the exposure.
Consumer exposure
It is not possible to conduct an EASE-calculation on a mixture such as
ESBO.
Living in a painted house, which is painted once a year has been
assumed to be a worst-case situation.
As the most important toxic feature of ESBO is oral toxicity, living in
a painted house is not expected to result in severe effects.
It cannot be excluded that consumers may ingest minor amounts of ESBO
during the yearly work with painting in the house. The most sensitive
persons may develop effects as described in the following section.
Environmental exposure of humans
Environmental exposure of humans and exposure of the environment cannot be
assessed by EUSES or EASE due to lack of data. However, the prominent
physical-chemical feature of ESBO is the LogPow, which is
relatively high. Exposures from the environment will therefore be expected
from particulate phases (soil and sediment) and possibly from biological
material.
The most significant toxicity data on ESBO are presented in Table 5.51.
Table 5.51 Selected toxicity data on ESBO.
Toxicology |
Species |
Protocol |
Dose levels / duration |
Results |
Ref. |
Acute oral toxicity |
Rat |
N.D. |
5,000, 21,000 - 40,000 mg/kg bw. |
5,000 mg/kg caused dyspnoe and diarrhoea.
LD50>5,000 mg/kg bw. |
1 |
|
|
N.D. |
N.D. |
LD50>5,000 mg/kg bw |
|
Acute inhalation toxicity |
- |
|
|
|
|
Acute dermal toxicity |
Rabbit |
N.D. |
Occlusion (24 hours) |
LD50>20,000 mg/kg bw |
1 |
Acute toxicity, other routes |
- |
|
|
|
|
Irritation
- skin |
Rabbit |
EPA, Federal reg., Vol 43, No.163 |
Occlusion (24 hours) |
Not irritating |
1 |
- eye |
Rabbit |
EPA, Federal reg., Vol 43, No.163 |
0.5 ml instillation |
Not irritating |
1 |
Sensitisation |
Guinea pig |
N.D. |
Induction, i.c. injections, rechallenge with patch tests |
Not sensitising |
1 |
Repeated dose toxicity |
Rat |
N.D. (oral) |
0.25% and 2.5%
2 years |
NOAEL=1.3 mg/kg bw. Slight injury in uterus at 2.5%.
|
1 |
|
Rat |
N.D. |
10 g/kg bw. Epoxide no. 14.6 - 111.5
Up to 10 weeks |
Slow growth, death in group receiving ESBO with epoxide
no.>49.7. E.No. 105-111.5 – severe degeneration of testes. |
1 |
|
Rat |
N.D. (oral) |
1.4 g/kg/ appl.,
2 appl. / week
16 months |
NOAEL=1.400 mg/kg
(effects not mentioned) |
1 |
Genetic toxicity |
Salmonella typhimurium
Mouse lymphoma cell, L5178Y |
Ames test
+/- |
N.D
|
Not mutagenic
Not mutagenic |
1
1 |
Reproductive / developmental toxicity |
Rat |
OECD 415
(gavage) |
100, 300 and 1000 mg/kg bw.0-250
mg/kg |
NOAEL, parental=1,000 mg/kg bw; NOAEL, offspring=1,000 mg/kg bw.
Severe degeneration of testes in animals treated with compound with
epoxide no. 105-111.5. |
1 |
Carcinogeni-city |
Rat |
N.D. (Oral)
|
<2.5% (1.4 g/kg bw). |
No evidence of carcinogenicity. |
1 |
Experience with human exposure |
Human |
Inhalation |
|
Asthma developed in a worker exposed to vapour from heated
polyvinyl chloride film containing ESBO. Challenge with ESBO vapour
of unspecified concentration produced asthmatic symptoms within 5
min. |
1 |
References: 1) European Commission Joint Research Centre (1996)
Observations in humans
A worker exposed to vapours from heated polyvinyl chloride film containing
ESBO developed asthma. Challenge with ESBO vapour of unspecified
concentration produced asthmatic symptoms within 5 min (European
Commission Joint Research Centre, 1996).
Acute toxicity
In the acute oral tests LD50 in rats ranged between
21,000-40,000 mg/kg bw. indicating low acute oral toxicity. Acute dermal
toxicity was low as well; LD50<20,000 mg/kg bw (European Commission
Joint Research Centre, 1996).
Irritation
ESBO was shown to be not irritating to skin (European Commission Joint
Research Centre, 1996).
Sensitisation
Sensitisation has not been observed in the reviewed data (European
Commission Joint Research Centre, 1996).
Repeated dose toxicity
ESBO was found to produce slight injuries in uterus of rats in a repeated
dose toxicity study (European Commission Joint Research Centre, 1996).
Genetic toxicity
In the reviewed data ESBO has not been seen to be mutagenic (European
Commission Joint Research Centre, 1996).
Mutagenicity testing was conducted on two plasticisers commonly used in
plastic clingfilm manufacturing, acetyl-tributylcitrate and epoxidized
soy-bean oil. There are no records of mutagenic testing using a bacterial
screening method for these two compounds. The two plasticisers were
screened using mutant strains of Salmonella typhimurium. The tests
indi-cated that they were not mutagenic (Heath & Reilly 1982).
Long term toxicity
Based on the limited available data, ESBO was not found to be a potential
carcinogen or to exhibit reproductive toxicity. Severe degradation of
testes has been observed with test material characterised by a high
epoxide no. (105-111.5) (European Commission Joint Research Centre, 1996).
NOAEL/LOAEL
In a repeated dose toxicity study in rats a NOAEL of 1.3 mg/kg bw. has
been identified. At the higher concentration, slight injury in uterus
appeared. In reproductive toxicity tests in mouse and rat, the NOAEL for
the parental group was 1,000 mg/kg bw and the NOAEL for the F1 offspring
were 1,000 mg/kg bw (European Commission Joint Research Centre, 1996).
Critical effect
The critical effect based on the available data appears to be repeated
dose toxicity following oral administration and reproductive toxicity.
Classification
The substance is not classifiable based on available data.
Summary of known toxicity
Based on the available data ESBO can only be regarded as slightly acute
toxic by oral exposure. A TDI of 1 mg/kg has been allocated from the EU
Scientific Committee for Food (SCF, 2000).
Generally, some data on environmental effects from ESBO are available,
especially from acute aquatic test systems. In the following the most
sensitive data are presented.
Table 5.52 Ecotoxicity and fate data on ESBO.
ESBO |
Aquatic
(mg/l) |
|
|
|
Terrestrial |
Bioaccumulation |
Biodegradation
(%) |
|
Algae |
Crustaceans |
Fish |
Microorganisms |
|
|
Aerobic |
Anaerobic |
|
|
|
|
|
|
BCF |
28 days |
|
Acute |
N.D. |
8
(24 hrs) |
900
(48 hrs) |
>100
(3 hrs) |
N.D. |
N.D. |
78-79
(at 2 or 10 mg/l) |
N.D. |
Chronic |
N.D. |
N.D. |
N.D. |
N.D. |
N.D. |
- |
- |
- |
N.D.: No data available.
Aquatic and terrestrial ecotoxicity
No data from test following standard methodology were available. All test
results are from test with a shorter duration. Despite the shorter test
duration ESBO was shown to be toxic (LC50=8 mg/l) to the
crustacean Daphnia magna in a 24 hours test (European
Commission Joint Research Centre, 1996). ESBO could be classified as toxic
to crustaceans but a more precise classification is not possible on the
basis of the present data.
ESBO was not toxic to the freshwater fish Leuciscus idus in a 48
hours acute toxicity test (European Commission Joint Research Centre,
1996).
Bioaccumulation
No BCF data were available. The estimated Log Pow >6
indicate that ESBO is bioaccumulative.
Aerobic and anaerobic biodegradation
ESBO is ready biodegradable according to the results of two standard OECD
tests.
Risk assessment
The PNEC for ESBO is 0.008 mg/l based on the available data and an
assessment factor on 1,000 (only test results from two trophic levels).
The data availability is insufficient for calculating PEC and therefore
no risk assessment of ESBO is possible.
Physical-chemical properties
The water solubility of dipropylene glycol dibenzoate (DGD) is 1.5 mg/l at
25 C. The magnitude of the water solubility
of DGD, places this substance in the group of less water soluble among the
substances investigated.
DGD has a vapour pressure of 4.7 10-7
mmHg at 25 C, which when compared to the
nine other substances is of smaller magnitude.
Only an estimated LogPow of 3.88 value is available
on DGD. The magnitude of this parameter indicates that DGD has lipophilic
properties.
Migration
Migration data on DGD has not been identified.
Use pattern for compound
Information on the production and uses of DGD has not been located. The
main uses of DGD may be in adhesives and fillers, cf. Table 4.6.
Exposure in the work place
The EASE calculation focuses on the production of adhesives and fillers.
The following assumptions are made with regard to the workplace
exposure:
- production takes place at a temperature of 20 °C
- required legal exhaust ventilation is in place
- contact with the substance will only take place incidentally, e.g.
in relation to cleaning and maintenance of production equipment.
Based on this scenario the EASE calculation provides the results shown
in Table 5.53.
Table 5.53 Estimated values of DGD in the working environment
according to the EASE calculation
Route of exposure |
EASE value |
Unit |
Vapour concentration in air for workers |
0.5-3 |
ppm |
Vapour concentration in air for workers |
7.12-42.7 |
mg/m3 |
Potential dermal uptake for workers |
0 |
mg/kg/day |
Consumer exposure
In the calculation in EASE, focus is on normal use of the bathroom in a
private household.
Based on this scenario the EASE calculation gives the results shown in
Table 5.54.
Table 5.54 The estimated potential daily intake of DGD by
consumer according to the EASE calculation
Route of exposure |
Daily intake in mg/kg bw/day |
Ratio of the ADI |
Inhalatory intake |
5.82 x 10-6 |
* |
Dermal uptake |
8.04 x 10-13 |
* |
Oral intake |
0 |
* |
Total chronic uptake via different routes |
4.36 x 10-6 |
* |
Total acute uptake via different routes |
0 |
* |
*: The ADI is not established
Environmental exposure of humans
The slight lipophilic properties of DGD cause the compound to accumulate
in a minor degree in fish. A measured BCF is not available.
Table 5.55 The estimated regional concentrations of DGD in
fish, plants, meat and milk.
Articles of food |
Wet fish |
Plants |
|
|
Meat |
Milk |
DGD |
estimate |
measured |
Roots |
Leaves |
Grass |
|
|
|
mg/kg |
mg/kg |
mg/kg |
mg/kg |
mg/kgww |
mg/kgww |
mg/kgww |
Estimation (~ 200 t) |
0.1 |
N/A |
0.007 |
0.0028 |
0.0028 |
8 10-6 |
2 10-6 |
Worst case (10,700 t) |
1.3 |
N/A |
0.093 |
0.0051 |
0.0051 |
1.03 10-4 |
3.3 10-5 |
Exposure in the environment
DGD has lipophilic properties based on an estimated LogPow and
this will tend to distribute the compound to the particulate phases.
Table 5.56 The estimated regional concentrations of DGD in
water, soil and air.
Compartment |
Aquatic
(mg/l) |
|
|
Terrestrial |
|
|
|
Air |
DGD |
Surfacet |
Surfaced |
Sediment |
Natural |
Agricultural |
Porewater of agri. soil. |
Industrial |
|
|
mg/l |
mg/l |
mg/kg |
mg/kg |
mg/kg |
mg/l |
mg/kg |
mg/m3 |
Estimation (~ 200 t) |
0.0004 |
0.0004 |
0.02 |
0.0004 |
0.003 |
0.0001 |
0.007 |
1 10-8 |
Worst case (10,700 t) |
0.0032 |
0.0032 |
0.17 |
0.0220 |
0.046 |
0.0013 |
0.346 |
5.8 10-7 |
Secondary poisoning
No BCF value is available. The LogPow is relatively high (3.88)
and secondary poisoning cannot be excluded. However, if DGD occurs under
acidic or basic conditions hydrolysis of the ester bond may take place
producing the benzoic acid and diethylene glycol. Whether this also may
occur to some extent in the environment is not clear, and no data on
hydrolysis is available for DGD.
Benzoic acid occurs in nature in free and combined forms. It has been
used over many years as a preservative in foodstuffs in concentrations up
to 0.1%. The human intake from natural sources is low compared to the
contribution from foodstuffs (Thorup 1999). An ADI has been assigned by
FAO/WHO (cf. Thorup, 1999) of 5 mg/kg bw for benzoic acid.
Table 5.57 The estimated human doses of DGD through intake of
water, fish, leaf of crops, roots of crops, meat, milk and air.
DGD |
|
Estimation (~ 200 t) |
Worst case (10,700 t) |
|
|
mg/kg/d |
mg/kg/d |
Drinking water |
|
0.00001 |
0.00009 |
Fish |
BCF estimated* |
0.0002 |
0.0021 |
Plants |
|
|
|
|
Leaf crops |
4.80 10-6 |
8.67 10-5 |
|
Root crops |
0.00004 |
0.00051 |
Meat |
|
3 10-8 |
4.4 10-7 |
Milk |
|
2 10-8 |
2.6 10-7 |
Air |
|
3 10-9 |
1.3 10-7 |
Total regional |
|
0.0003 |
0.0028 |
* Measured BCF value not available
Summary of known toxicity
There is not sufficient data to describe the toxicity of the substance.
Some benzoic acid derivatives will hydrolyse in aqueous solutions,
especially in the acidic gastro-intestinal environment. Information
regarding this property is not available for DGD. If the ester bonds of
DGD are hydrolysed before exposure of humans this would significantly
change the toxicological properties. The resulting benzoic acid is a
compound well known to man and it is permitted for conservation purposes
in food (Thorup, 1999).
No data on the environmental effects from DGD are available.
Aquatic and terrestrial ecotoxicity
No data on aquatic and terrestrial ecotoxicity of DGD were available, and
there is no information regarding toxicity to microorganisms. Preliminary
QSAR estimates by Danish EPA lead to the classification N; R50/53 (May
cause long term effects in the aquatic environment).
Bioaccumulation
No BCF data on DGD were available. The estimated Log Pow of
3.88 (Syracuse Research Corporation, 2000) indicate that DGD is
potentially bioaccumulative.
Biodegradation
No data were available on aerobic or anaerobic biodegradation of DGD.
Risk assessment
The data availability is insufficient for calculating PNECs or providing
other indications of ecotoxicity for the assessment of risk of DGD.
In parallel with case for humans some benzoic acid derivatives will
hydrolyse in aqueous solutions, especially in an acidic environment. This
would significantly alter the ecotoxicological and fate properties
relative to the parent substance. Benzoic acid occurs naturally, e.g. in
berries (Thorup, 1999). Information regarding this property is not
available for DGD.
Sebacates are used to impart good low temperature flexibility similarly
to adipates and azelates, and generally have the same plasticising
properties (Gächter and Müller, 1993).
Physical-chemical properties
Dioctyl sebacate (DOS) is in fact the ethylhexyl rather than the octyl
compound, but is usually referred to as DOS, and this denotion is kept
here. DOS has very low water solubility. The data range from ‘insoluble’
to an estimated 0.35m g/l. The
upper end of the water solubility range places DOS among the most water
insoluble substances assessed here.
The estimated log octanol-water partition coefficient of 10 indicates
that DOS is a very lipophilic compound when compared to the other
substances in this assessment.
DOS has an estimated vapour pressure of 1.0´10-7 mm Hg at 25 C, which is
moderate among the investigated substances.
In the same chemical family, dibutyl sebacate exhibits the
characteristics of a slightly smaller compound with higher water
solubility, a higher vapour pressure, and it will presumably be less
lipophilic. For the EUSES calculation DOS has been set at the maximum
octanol-water partition coefficient allowed (LogPow = 6) and
the lowest possible water solubility.
Migration
A British study of retail food wrapped in plasticised PVC showed
considerably higher concentrations of dibutyl sebacate in several food
products (76-137 mg/kg) than various phthalate esters, acetyl tributyl
citrate and diphenyl 2-ethylhexyl phosphate, which were typically less
than 10 mg/kg (Castle et al., 1988b).
Use pattern for compound
The main uses of DOS is anticipated to be in printing ink and adhesives,
cf. Table 4.6.
Exposure in work place
The EASE calculation focuses on the production of printing inks.
The following assumptions are made with regard to the workplace
exposure:
production takes place at a temperature of 30 °C
required legal exhaust ventilation is in place
contact with the substance will only take place incidentally, e.g. in
relation to cleaning and maintenance of production equipment.
Based on this scenario, the EASE calculation provides the results shown
in Table 5.58.
Table 5.58 Estimated values of DOS in the working environment according
to the EASE calculation
Route of exposure |
EASE value |
Unit |
Vapour concentration in air for workers |
0.5-3 |
ppm |
Vapour concentration in air for workers |
8.87-53.2 |
mg/m3 |
Potential dermal uptake for workers |
0 |
mg/kg/day |
Consumer exposure
In the calculation in EASE focus is on half an hour daily reading of
magazine containing printing ink.
Based on this scenario the EASE calculation gives the results shown in
Table 5.59.
Table 5.59 The estimated potential daily intake of DOS by consumer
according to the EASE calculation
Route of exposure |
Daily intake in mg/kg bw/day |
Ratio of the ‘ADI’ (0.05 mg/kg bw/day)a
% |
Inhalatory intake |
5.82 x 10-6 |
5.01 x 10-2 |
Dermal uptake |
8.04 x 10-13 |
1.61 x 10-9 |
Oral intake |
0 |
0 |
Total chronic uptake via different routes |
4.36 x 10-6 |
8.72 x 10-3 |
Total acute uptake via different routes |
0 |
0 |
a The Group restriction value of 0.05 mg/kg
bw/d is based on DEHP peroxisome proliferation data (which is considered
conservative).
Environmental exposure of humans
The amount established in ’Usage’ section is used calculate exposure
for a number of environmental compartments by EU TGD/EUSES. The dose is
almost completely derived from consumption of root crops. This is due to
the extraordinary high LogPow of DOS leading to accumulation in
agricultural soil. No measured data are available for accumulation in
plants.
In consideration of the large differences between measured and
estimated BCFs, care must be exerted in the interpretation of the actual
bioconcentration in the environment and estimates based on high LogPow.
This is also even clearer reflected in the roots crop dose. If the group
restriction value of 0.05 mg/kg bw/d is applied as an ‘ADI’, the ratio
to ‘ADI’ is higher than acceptable (almost 1 in ‘Estimation’,
almost 6 in ‘Worst case’), and further elucidation is necessary. A TDI
of 3 mg/kg bw/d is available for sebacic acid (SCF, 2000). Data are not
available to determine whether DOS will hydrolyse when ingested with root
crops.
Table 5.50 The distribution of DOS seen in relation to the accepted
daily intake.
DOS |
|
Estimation (1,500 t) |
Worst case (10,700 t) |
|
|
mg/kg/d |
mg/kg/d |
Drinking water |
|
3.0 x 10-6 |
2.2 x 10-5 |
Fish |
BCF estimate |
0.0015 |
0.011 |
Plants |
Leaf crops |
8.1 x 10-6 |
0.000058 |
|
Root crops |
0.037 |
0.27 |
Meat |
|
0.00023 |
0.0017 |
Milk |
|
0.00014 |
0.00098 |
Air |
|
8.7 x 10-8 |
6.2 x 10-7 |
Total regional |
|
0.039 |
0.28 |
Exposure in the environment
The estimated concentration levels of DOS indicate the expected very low
aqueous concentration due to the low solubility, and a high concentration
in the particulate phases (sediment and soils).
Table 5.61 The estimated regional concentrations of DOS in water, soil
and air.
Compartment |
Aquatic
(mg/l) |
|
|
Terrestrial |
|
|
|
Air |
DOS |
Surfacet |
Surfaced |
Sediment |
Natural |
Agricultural |
Porewater of agri. soil. |
Industrial |
|
|
mg/l |
mg/l |
mg/kg |
mg/kg |
mg/kg |
mg/l |
mg/kg |
mg/m3 |
Estimation (~ 1,500 t) |
0.00004 |
0.00002 |
0.5 |
0.3 |
1.2 |
0.00011 |
4.0 |
4 10-7 |
Worst case (10,700 t) |
0.00030 |
0.00014 |
3.3 |
2.2 |
8.8 |
0.00076 |
28.5 |
2.9 10-6 |
Secondary poisoning
DOS has a potential for secondary poisoning if the evaluation is based on
the estimated BCF alone and the estimated LogPow. The ADI is
exceeded in the worst case scenario, and nearly so in the estimation
scenario. The dose is almost completely derived from consumption of root
crops. This is due to the extraordinary high LogPow of DOS
leading to accumulation in agricultural soil. No measured data are
available for accumulation in plants.
In consideration of the large differences between measured and
estimated BCFs, care must be exerted in the interpretation of the actual
bioconcentration in the environment and estimates based on high LogPow.
However, a dibutyl derivative of sebacic acid has been shown to hydrolyse
in the gastro-intestinal fluid. Whether this also may occur to some extent
in the environment is not clear, and no data is available for DOS. The TDI
of sebacic acid (3 mg/kg bw) is 60 times higher than the value for DOS.
Table 5.62 The estimated regional concentrations of DOS in fish,
plants, meat and milk.
Articles of food |
Wet fish |
Plants |
|
|
Meat |
Milk |
DOS |
estimate |
measured |
Roots |
Leaves |
Grass |
|
|
|
mg/kg |
mg/kg |
mg/kg |
mg/kg |
mg/kgww |
mg/kgww |
mg/kgww |
Estimation (~ 1.500 t) |
0.92 |
n/a |
6.8 |
0.0005 |
0.0005 |
0.54 |
0.017 |
Worst case (10,700 t) |
6.58 |
n/a |
48.5 |
0.0034 |
0.0034 |
0.39 |
0.122 |
The most significant toxicity data on DOS are presented in Table 5.63.
Table 5.63 Selected toxicity data for DOS.
Toxicology |
Species |
Protocol |
Dose levels / duration |
Results |
Ref. |
Acute oral toxicity |
Rat |
N.D. |
|
LD50=1,280 mg/kg bw. |
4 |
Acute inhalation toxicity |
Rat |
N.D. |
250 mg/m3 for 4 hours |
No adverse effects observed |
1 |
Acute dermal toxicity |
- |
|
|
|
|
Acute toxicity, other routes |
Rat
Rabbit |
N.D. (i.v.)
N.D. (i.v.) |
|
LD50=900 mg/kg bw.
LD50=540 mg/kg bw |
4 |
Irritation
- skin |
N.D. |
N.D. |
N.D. |
Not irritating, not absorbed through skin. |
2 |
- eye |
- |
|
|
|
|
Sensitisation |
- |
|
|
|
|
Repeated dose toxicity |
Rat |
N.D. (inhalation study) |
250 mg/m3 for 4 hrs/d, 5 d/week, 13 weeks |
No adverse effects observed |
1 |
|
Rat (♂) |
N.D. (oral) |
1 g/kg bw/day
3 weeks |
Increased liver weight, peroxisome proliferation, increased levels of
peroxisome enzymes |
1 |
Genetic toxicity |
Salmonella typhimurium |
Ames test |
N.D |
Not mutagenic |
3 |
Reproductive / developmental toxicity |
Rat |
N.D. (oral) |
10 mg/kg bw/day (19 months) |
No effects observed |
2 |
Carcinogeni-city |
Rat |
N.D. (oral) |
10 mg/kg bw/day (19 months) |
No effects observed |
2 |
Experience with human exposure |
Human |
- |
60 mg/m3; 1 min
Inhalation |
Reported threshold of irritant action on mucous membranes of upper
resp. tract and eyes. |
1 |
|
Humans |
- |
48 h covering and patch test |
No effects observed |
1 |
References: 1) BIBRA (1996), 2) HSDB (2000), 3) CCRIS (2000), 4) NTP (2000)
Observations in humans
Volunteers did not produce signs of irritation or
sensitisation during a 48 hours covering and patch test (BIBRA, 1996).
DOS aerosols have been used to demonstrate particle deposition in lungs and
respiratory tract, apparently without producing overt toxic effects.
Exposure to 60 mg/m3 for 1 minute is reported to be the threshold
of irritant action on the mucous membranes of the upper respiratory tract and
eyes. No further details are available (BIBRA, 1996).
Acute toxicity
The oral LD50 for rats is found to be relatively low equal to 1,280
mg/kg bw (NTP, 2000).
No adverse effects were observed when rats were exposed to a concentration of
250 mg/m3 for 4 hours.
Irritation/Sensitisation
Exposure to DOS
did not cause irritation or sensitisation on skin in human volunteers during 48
hours covering and patch tests (HSDB 2000).
Repeated dose toxicity
Adverse effects were also not seen in a 13 weeks study where 12 rats were
exposed to 250 mg/m3 for 4 hours per day, 5 days a week (BIBRA,
1996).
Genetic toxicity
DOS was not found to be mutagenic in Ames test.
Long term toxicity
Rats fed a diet containing 10 mg/kg bw for up to 19 months did not show any
carcinogenic effects and the reproduction was normal in a 4 generation study of
rats fed about 10 mg/kg bw (HSDB 2000).
NOAEL/LOAEL
A NOAEL or LOAEL has not been established, but a dose of 10 mg/kg bw did not
produce any carcinogenic effects or reprotoxic effects in 19 month feeding
studies in rats (HSDB 2000).
Critical effect
The critical effect based on the available data is the acute toxic effect
following oral administration.
Classification
The critical effect based on the available data is the acute toxic effect
observed in rats following oral administration. Effects include reduced
co-ordination, laboured breathing and diarrhoea, with tissue damage in the
liver, spleen, brain and heart (Bibra 1996).
Summary of known toxicity
DOC exhibits moderate acute toxicity when administered orally to rats and
fulfils the criteria for classification as harmful if swallowed.
The substance does not seem to be an irritant or a sensitiser.
Repeated oral administration to rats showed effects on the liver but no signs
of carcinogenicity or reproductive toxicity were seen in rat studies.
Daily intake
The EU's Scientific Committee for Food has defined a group restriction for DOS
and other dialkyl esters equal to 0.05 mg/kg bw/day (SFC 2000).
Exposure versus toxicity
A comparison between the calculated exposure of consumers and the
available toxicological information about DOS indicates that the selected
exposure scenario represents a minor risk to human health.
General exposure of the population may occur through dermal contact with
consumer products containing DOS and ingestion of contaminated food. Based on
the selected scenario, the EASE-calculation indicates that the exposure of DOS
in consumers represents for some routes very small values and therefore probably
constitutes a limited contribution to the overall exposure of consumers. However
the inhalation of the product represents a relatively high ratio of the daily
intake at a level (0.05%). As seen in Table 5.64 this means that the intake of
fish and root crops might be of concern.
Concerning exposure in the working environment, exposure may occur through
inhalation of dust particles and dermal contact when working in places where DOS
is handled. The EASE-calculation indicates that the concentration of DOS in the
working environment of the selected scenario can reach levels of up to 53.2 mg/m3
and 3 ppm.
Table 5.64 Ecotoxicity and fate data on DOS.
|
Aquatic
(mg/l) |
|
|
|
Terrestrial |
Bioaccumulation |
Biodegradation (%) |
|
Algae |
Crustaceans |
Fish |
Microorganisms |
|
|
Aerobic |
Anaerobic |
|
|
|
|
|
|
BCF |
28 days |
|
Acute |
N.D. |
N.D. |
N.D. |
N.D. |
N.D. |
45,000 |
N.D. |
N.D. |
Chronic |
N.D. |
N.D. |
N.D. |
N.D. |
N.D. |
(estimate) |
N.D. |
N.D. |
Aquatic and terrestrial ecotoxicity
No data on ecotoxicity has been identified for DOS or dibutyl sebacate. Sebacic
acid is generally considered relatively safe (see ‘secondary poisoning’),
but no data on hydrolysability is available. Aquatic or terrestrial PNECs cannot
be calculated with basis in data on DOS.
Bioaccumulation
Only an estimated BCF is given indicating high bioaccumulation potential
(Syracuse Research Corporation, 2000).
Aerobic and anaerobic biodegradation
The high lipophilicity of DOS and other sebacate plasticisers will generally
lead to low bioavailability to microorganisms in STP. The biodegradation of
phthalate esters is relatively slow due to a lag phase, but complete
mineralisation is possible under anaerobic conditions (Kleerebezem et al.,
1999).
Risk assessment
The data availability is insufficient for calculating PNECs or providing other
indications of ecotoxicity for the assessment of risk of DOS or dibutyl
sebacate.
Based on the experience with phthalates and the physical-chemical properties
of DOS, it must be assumed that the potential for environmental effects is
associated with the accumulation of the compound in biota, in aquatic sediments
and in soils amended with sewage sludge.
Physical-chemical properties
Polyester plasticisers are polymers based on divalent acids, such as adipic,
sebacic or azelaic acid (some times also on phthalic acid) condensed with diols.
The polycondesation reaction yields a more or less broad molecular weight
distribution of the polyester plasticiser, and the end product will display an
average molecular weight, which is specific for the individual polymer.
Typically, the polyester is a polymer with a molecular weight between 850 and
3500 (Gächter, Müller 1993).
Migration
The polyesters of high viscosity have a good resistance to hydrocarbons, and
primarily due to their high molecular weight they show little tendency to
migration (Castle et al., 1988a).
Exposure
Due to the chemical nature of polyester plasticisers, the substance data (e.g. a
specific molecular weight) required for a quantitative estimate of distribution
and concentration by models are not available.
Human health assessment
A polyester based on adipic acid and 1,2-propanediol is frequently used in
plasticising PVC, and has been suggested for the assessment. The EU Scientific
Committee for Food has a range of polyesters of adipic acid, azelaic acid and
various diols in their Synoptic list regarding substances in food contact
materials (European Commission, 2000). Limited studies based on a polyester (end
capped with fatty acids) are quoted, and a group TDI of 0.5 mg/kg bw/d has been
allocated.
The parent compounds adipic acid and 1,2-propanediol have been considered by
the same committee in food contact materials. Human health ADI of 5 mg/kg bw/d
has been allocated to adipic acid and an ADI of 25 mg/kg bw/d allocated to
1,2-propanediol.
Environmental assessment
No data on the polymer has been identified for the environmental assessment.
Comparing polyester plasticisers with the lower molecular weight parent
substances will lead to the following generalised pattern. The polyester will
have
- little bioavailability (MW >> 600)
- low volatility
- high tendency to bind to particles
- low or insignificant biodegradability
Risk assessment
All in all, the above characterises an inert substance in the environment, which
will not enter the biosphere until the polymeric structure begins to break.
Thus, if these substances do not release large quantities of mono- or oligomers,
the possible effects should be associated with very long-term exposure or
accumulation. Information on this issue has not been identified.
The high molecular weight of the substances places polyester plasticisers are
in a borderline area approaching the polymer materials with respect to the
evaluation of risk to man and environment.
|